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i 
Abstract 
 
Method Development for Characterization of N-linked Glycoproteins in Mass 
Spectrometry 
 
by 
 
2007 
 
Ying Zhang 
 
Doctor of Philosophy in Chemistry 
 
University of Kansas 
 
Advisor: Dr. Heather Desaire, Chair  
 
 Protein glycosylation is one of the most important post-translational 
modifications, and it is involved in many biological processes, including inter-/intra 
cell signaling, protein recognition, and receptor binding, etc. It is estimated that 50-
60% of cell-surface and secreted proteins are glycosylated. Alteration in the glycan 
structures on these proteins has been implicated in various disease states, such as, 
cancer, Alzheimer’s disease, rheumatoid arthritis, and chronic obstructive pulmonary 
disease, etc. Thus, characterizing glycans and monitoring the changes of glycan 
profiles on proteins are essential to elucidate their biological significance and 
facilitate disease diagnosis.  
Mass spectrometry is a powerful tool for characterizing glycans on proteins, 
due to its high sensitivity, selectivity and small sample requirements for analysis. In 
order to elucidate a variety of glycan profiles (including both neutral and acidic 
glycans) on glycoproteins, several efficient MS-based approaches have been 
developed, and they are described herein. These approaches include an ion-pairing 
strategy in conjunction with ESI-MS/MS to identify the acidic functional groups 
(sulfate, and phosphate) in carbohydrates and glycopeptides; and a glycopeptide-
ii 
based MS approach (liquid chromatography followed by MALDI-TOF/TOF) to 
characterize glycans on different glycoproteins that vary in the number of 
glycosylation sites and their corresponding glycan profiles.  
Aside from protein glycosylation, disulfide connectivity is another important 
modification present in proteins, and it plays a key role in establishing/maintaining 
protein structures in their biologically active forms. Therefore, determination of 
disulfide bond arrangement provides chemical structural information about proteins, 
and it may lead to insights into their functional roles. To achieve this goal of 
determining disulfide bonding patterns in proteins, a mass spectrometric approach 
using liquid chromatography followed by electrospray ionization-Fourier transform ion 
cyclotron resonance mass spectrometry (LC/ESI-FTICR-MS) has been validated and 
used to determine the disulfide bond arrangement in an HIV envelope protein. This 
study contributes to the understanding of this protein’s structure, and these findings 
are essential in understanding and improving the protein’s immunogenicity.  
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Chapter I 
Introduction 
1.1 Mass spectrometry 
During past two decades, mass spectrometry has emerged as a powerful and 
variable tool, which has been widely used in fundamental studies and analytical 
applications.1-3 This technique measures the molecular mass of a molecule 
according to its mass-to-charge ratio (m/z). Typically, a mass spectrometer consists 
of three basic components: an ionization source, mass analyzer, and detector;1 see 
Figure 1. Gas-phase ions are initially generated from a solid or liquid form in the 
ionization source by gaining or losing a charge on the neutral molecules.4 The 
charged gas-phase ions are electrostatically drawn into a mass analyzer, separated 
based on the m/z ratio and then detected by a detector.1 The generated mass 
spectrum provides the molecular masses of these ions.  
There are several soft ionization techniques that have been widely used in 
the studies of glycomics, proteomics and glycoproteomics, etc. These soft ionization 
techniques consist of fast atom bombardment (FAB)5-8, matrix-assisted laser 
desorption/ionization (MALDI)1, 9-17 and electrospray ionization (ESI)1, 3, 14. Among 
these ionization sources, two ionization processes -MALDI and ESI- are used in the 
research presented herein. Therefore, the fundamentals of these two ionization 
sources will be discussed in the following sections. The principles as well as the 
application of FAB can be found in references 5 through 8. 
2 
 
 
Figure 1. Schematic representation of the three basic components in mass 
spectrometry and their functions; the ions are produced in the ionization source, 
separated in the mass analyzer according to their m/z ratio, and then detected in a 
detector. 
  
1.2 Matrix-assisted laser desorption/ionization (MALDI) 
MALDI is one of the soft ionization processes to produce charged ions for 
biologically relevant molecules with molecular masses up to 300 kDa.18, 19 MALDI 
mass spectrometry (MALDI-MS) was invented in 1988 by Tanaka, Karas, and 
Hillenkamp.19 Since then, it has become one of the essential techniques in the 
identification of proteins and their corresponding post-translational modifications 
(PTMs) with high sensitivity, selectivity and throughput.4, 15, 18, 20 The invention of this 
technique was a landmark, in that it provided an opportunity to apply mass 
spectrometry to the analysis of non-volatile, complex biological samples.4, 18 
The MALDI ionization process initiates with mixing the sample with an excess 
amount of matrix solution and spotting the sample:matrix mixtures on the MALDI 
target plate. The crystallized sample:martrix mixtures are then irradiated by a laser 
beam to extract and ionize the analytes, as well as matrix molecules, into the gas 
phase, as shown in Figure 2. Although this process is still not well understood, it is 
generally believed that the matrix molecules absorb a large amount of the photon 
energy from the laser beam and subsequently transfer that energy to the analytes in 
a certain way that the sample molecules sublime to the gas phase as intact ions.18, 19, 
3 
21  
Two mechanisms have been proposed to explain how the charged analytes 
are formed in MALDI ionization process.22, 23 The first mechanism shows a two-step 
ionization event: a primary ionization process, followed by a secondary in-plume ion-
molecule reaction.22 The matrix molecules are ionized in the first step and then 
undergo a secondary ion-molecule charge-transfer reaction with neutral analyte 
molecules in the expanding gas plume produced on the matrix surface; See Equation 
(1.1).  
M+ + A → M + A+                                                        (1.1) 
Where M+ is the charged matrix molecule that could be protonated, sodiated, or 
deprotonated; A is the neutral analyte which participates the ion-molecule reaction to 
obtain the charge from the matrix molecule (M). The ion-molecule reactions between 
the charged matrix molecule and the neutral analyte might be proton transfer, cation 
transfer, electron transfer, or electron-capture reactions. In this model, the primary 
ionized matrix molecules are produced by laser excitation and the in-plume ion-
molecule reaction plays a predominant role in the analyte ionization process.18, 19, 21  
The second mechanism of analyte ionization is to produce the matrix-analyte 
clusters, followed by ionization of these clusters.23 Two models have been proposed 
in this mechanism to explain how to charge the formed matrix-analyte clusters in 
MALDI ionization process. One model assumes that the analytes are present in a 
multiply charged form in the matrix.23 The clusters are produced through trapping the 
multiply charged analytes as well as their counter-ions in the matrix. The generated 
and charged clusters are released in the plume by laser irradiation. During this 
process, the charged analyte molecules are generated from these matrix-rich 
4 
clusters via desolvation. The highly charged initial analytes cannot survive in the 
plume due to high charge-charge repulsion in the gas phase.18, 22, 23 Therefore, these 
highly charged analytes undergo a charge reduction process, in which they are 
neutralized by the electrons produced by laser irradiation on the matrix.22 During this 
process, only the singly charged ions are the lucky survivors in the plume. This 
explains why most gas phase ions produced in MALDI are singly charged. The 
second model of charging the formed matrix-analyte clusters is photoionization with 
normally used laser systems, such as N2 (337 nm) laser and the frequency-tripled 
Nd:YAG (355 nm) laser, etc.18, 19, 21  
In the desorption and ionization process discussed above, the generated 
analyte ions are mainly singly charged molecules. With the increases in the 
molecular masses of the sample molecules, the likelihood of forming oligomeric ions 
(e.g. doubly and triply charged ions) in MALDI becomes higher. Sodiated adducts 
are also a characteristic feature in the analysis of the biologically relevant samples 
by MALDI. In addition to the analysis of positively charged ions, the analysis of 
negatively charged ions is also possible with the MALDI ionization technique.1, 9-11, 18-
20 
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Figure 2. Matrix-assisted laser desorption/ionization process. (Adapted from Chhabil 
Dass, Fundamentals of Contemporary Mass Spectrometry, Wiley-interscience, New 
York, 2007.) 
 
1.2.1 Laser systems in MALDI  
In MALDI analysis, there are several important factors that need to be 
considered when performing the experiments, such as the laser system and the 
selected matrix solution. A diversity of laser systems has been applied in MALDI 
analysis, including UV lasers and IR lasers. UV lasers include the N2 laser (337 nm), 
the ArF excimer laser (193 nm), and the frequency-tripled (355 nm) / frequency-
quadrupled (266 nm) Nd:YAG lasers. IR lasers consist of the transversely excited 
atmospheric (TEA) CO2 laser (10.6  μm), the Q-switched Er:YAG laser (2.94 μm), 
and the Cr:LiSAF / Nd:YAG pumped optical parametric oscillator (OPO) lasers (3.28 
μm). These lasers are commonly used in MALDI systems and can produce the 
similar spectra in the analysis of biological samples.12, 18, 19 
1.2.2 Matrices for MALDI  
The MALDI matrix is another important part of the MALDI ionization process. 
Typically, the matrix used in MALDI desorption and ionization is a non-volatile solid 
material. It absorbs a large amount of photon energy from the laser beam and 
minimizes sample damage. The use of matrix can also reduce the inter-molecular 
forces among the sample molecules, thus decreasing sample aggregation. An ideal 
MALDI matrix is comprised of several characteristics: strong adsorption of laser 
energy to reduce sample damage; good solvent compatibility with analytes, to form 
well-defined crystals; low sublimation temperature, to facilitate the formation of a 
plume of the sample:matrix mixture by laser irradiation; and the ability to transfer 
charges to the analytes with high efficiency, through photochemical reactions.18, 19, 21  
6 
According to the characteristics of the ideal MALDI matrix, four classes of 
matrices have been widely used in the MALDI ionization process so far, including 
solid organic matrices, liquid organic matrices, ionic liquids, and inorganic materials. 
Solid organic matrices include α-cyano-4-hydroxycinnamic acid (CHCA), and 2,5-
dihydroxybenzoic acid (DHB), etc. These compounds are the most common types of 
matrices retaining an aromatic ring in the structure to facilitate absorbing laser 
irradiation. While a wide range of species can be analyzed with this type of matrices, 
(such as proteins, peptides, oligosacchrides, glycoproteins, and glycopeptides, 
etc),12 inhomogeneous distribution of the sample:matrix molecules in the crystallized 
solid phase exists when these matrices are used in MALDI analysis. Thus, spot-to-
spot variations and sample-to-sample variations are present during analysis. Liquid 
organic matrices (e.g. 2-nitrophenyloctyl ether and 3-nitrobenzyl alcohol) and ionic 
liquids produced by mixing an organic solid matrix with an organic base (such as 
butylamine), can be used to overcome inhomogeneous distribution in the sample 
preparation.18 Aside from organic compounds used in MALDI matrices, inorganic 
matrices such as metals, metal oxides, and graphitized carbon dispersed in a 
nonvolatile liquid are also used to mix with analytes and facilitate their detection in 
MALDI analysis.12, 18, 19, 21 
1.2.3 Advantages and disadvantages of MALDI 
MALDI produces charged molecules with little or no fragment ions; thus, it is 
a soft ionization technique that is applicable for the analysis of biomolecules, up to 
300 kDa in mass. It also has a high salt tolerance and high sensitivity, detecting 
samples at a femtomole to low picomole levels, which is suitable for the analysis of 
samples present in low abundance in complex mixtures. Since matrix is necessary in 
7 
MALDI experiments, matrix interference would be a problem for the analysis of 
compounds in a lower mass range (< 700 Da). In addition, the use of an acidic matrix 
in MALDI may also cause sample degradation on a certain types of compounds. 
Therefore, selecting a suitable matrix material to be compatible with the analytes, to 
avoid the sample degradation, is very important. Aside from matrix interference, the 
laser beam used in MALDI may cause sample photodegradation. Therefore, the 
laser energy needs to be controlled carefully in the experiments, to reduce sample 
damage.19  
1.2.4 Principles of time of flight (TOF) mass spectrometry 
Time of flight (TOF) is a widely used mass analyzer coupled with MALDI 
ionization sources. Briefly, this technique works based on the principle that the 
generated ions from MALDI are accelerated and electrostatically drawn to the TOF 
tube in a field free drift region, in which the ions are separated based on the mass-to-
charge ratio (m/z). Specifically, a positive voltage (V) is placed on the backing plate 
to produce an electric field within the source region, as shown in Figure 3. Prior to 
entering the field free drift region, all of the generated ions are accelerated to the 
same kinetic energy:  
½ mv2 = qV                                                              (1.2) 
where m= mass of the ion, v= velocity of the ion, q= charge of the ion, V= potential of 
the electric field. When the ions pass through the extraction grid, their velocities (v) 
are inversely proportional to the square root of their m/q (or m/z) values:  
v = (2qV/m)1/2                                                           (1.3)  
Subsequently, the ions travel in a long, field free drift region of length L and reach the 
detector at different times, depending on their velocity, as described below:  
8 
 t = L/v = L• [m/(2qV)]1/2                                             (1.4) 
Since L and V are constants, the time spent to reach the detector relies on the 
square root of m/q (or m/z) of the ions. The lower m/q (or m/z) ions migrate faster 
and reach the detector earlier than the higher m/q (or m/z) ions in the field free drift 
region. The resultant time spectrum can be converted to a mass spectrum by an 
equation as shown below:  
       m/q = (2V) • (t/L)2                                                     (1.5) 
From this equation, the m/q (or m/z) of the ions is proportional to the time they take 
to reach the detector. V and L are constants, determined by the experimental 
parameters in the instruments. Typically, the potential of the electric field V 
(accelerating voltage V) ranges from 3 kV to 30 kV, and the length of the TOF tube 
ranges from 15 cm to 8 m.1, 9-11, 18-20  
Although the conventional linear TOF mass spectrometer can be employed to 
separate and detect the gas-phase ions on the basis of m/z, it generally has poor 
mass resolution (less than 500) which is related to the temporal width of two ions of 
the same m/z values (∆t) upon reaching the detector. The mass resolution of a TOF 
mass spectrometer is shown in below: 
       R = t/(2∆t) = m/∆m                                                   (1.6) 
Where R = mass resolution, t = time that the ions spend to reach the detector, ∆t = 
the time interval of two ions of same m/z (s). Theoretically, if the ions of the same 
m/z value arrive at the detector simultaneously (∆t → 0), the mass resolution can be 
increased according to equation (1.6). However, practically, when the ions are 
generated and accelerated in the source region, due to the intrinsic distribution in 
time (instant of ion formation), space (initial locations of the ions in the source 
9 
region), and velocity (different initial kinetic energies on the ions), the two ions with 
the same mass will not reach the detector at the same time. These factors result in 
the poor mass resolution in the linear TOF mass spectrometer. To mitigate these 
limitations and improve the mass resolution in MALDI-TOF analysis, delayed 
extraction and reflectron devices are designed and incorporated in the MALDI-TOF 
instrument.1, 9-11, 18-20 
 
Figure 3. Schematic representation of mass separation in TOF analyzer; The ions 
are separated based on m/z. The ions with lower m/z (small circles) migrate faster 
than those with higher m/z (large circles). (Adapted from Chhabil Dass, 
Fundamentals of Contemporary Mass Spectrometry, Wiley-interscience, New York, 
2007.) 
 
1.2.5 Delayed extraction  
Delayed extraction is an efficient approach to increase the mass resolution of 
a linear TOF mass spectrometer, in which the ionization source region has been 
divided into two regions, a field-free extraction region and an acceleration region; as 
shown in Figure 4A. In the ionization process, the crystallized sample:matrix mixture 
10 
is irradiated by a laser beam to form gas-phase ions. During this process, no 
potential is applied to the extraction region. The ions oscillate randomly in the field-
free extraction region, in which the isomass ion with a higher initial velocity (e.g. ion 
a) moves faster than those with a lower initial velocity (e.g. ion b), therefore, the 
distance they travel away from the backing plate is different; see Figure 4A. 
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Figure 4. Schematic representation of delayed extraction in MALDI-TOF; The ions 
with the different initial velocities (v0) are extracted in a field free environment in the 
extraction region. After a few nanoseconds of delay, an acceleration pulse is applied. 
The ion b with a lower v0 is subjected into a higher potential field and accelerated to 
a higher velocity (vH). While the ion a is subjected into a lower potential field and 
accelerated to a low velocity (vL) prior to entering the field free drift region. In the field 
free drift region, the ion b continues to migrate closer to ion a and eventually they 
reach the detector at the same time.  
 
After a short period of delay, an acceleration potential is applied to accelerate 
the ions. Thus, the isomass ions are electrostatically drawn away from the ionization 
source. Due to the different distances away from the backing plate, the isomass ions 
with lower initial velocities (e.g. ion b) are subjected to a higher potential field than 
those with higher initial velocities (e.g. ion a); See Figure 4B. As a result, the ions 
with a lower initial velocity (e.g. ion b) are sped up to a higher velocity than those 
with a higher initial velocity (e.g. ion a). In the field free drift region, all of the ions with 
the same m/z values migrate closer to each other and eventually reach the detector 
at the same time.1, 9-11, 18, 20 
1.2.6 The reflectron 
Reflectron is another widely used device to mitigate the intrinsic spatial and 
energy distribution of gas-phase ions; thus, it improves the mass resolution in 
MALDI-TOF analysis. A reflectron is comprised of a series of retarding electrostatic 
mirrors with a progressively increasing potential, as shown in Figure 5. These mirrors 
are located at the end of the field free drift region, and they slow down the ions to 
zero velocity. The ions are then reaccelerated in the opposite direction, and they 
migrate in the second field free drift region. According to the differences in the initial 
spatial and kinetic energy distribution, the isomass ions with higher initial energy 
(e.g. ion a) will travel in a longer pathway in the reflectron region than those with 
lower initial energy (e.g. ion b). Therefore, the shorter flying time of the isomass ions 
12 
with higher initial energy (e.g. ion a) in the first field free drift region is compensated 
by penetrating the retarding field in the reflectron to a greater depth than those with 
lower initial energy (e.g. ion b). As a result, all of the ions with the same m/z values 
reach the second detector (D2) simultaneously.  This process enhances the mass 
resolution in MALDI-TOF.  
 
Figure 5. Schematic representation of the reflectron in a MALDI-TOF instrument; The 
ions a and b have the same m/z value but different initial kinetic energies. In the 
refletron mode, they are moving in a different pathway, but reach the second 
detector simultaneously. (Adapted from Chhabil Dass, Fundamentals of 
Contemporary Mass Spectrometry, Wiley-interscience, New York, 2007.) 
 
To date, both reflectron and delayed extraction have been incorporated into 
MALDI-TOF mass spectrometers to improve mass resolution in MALDI-TOF MS 
analysis. This provides a unique opportunity for applying MALDI in the 
characterization of proteins and their corresponding post-translational modifications, 
because these devices allow sufficient mass resolution to distinguish isotopes for 
large molecules, and they can detect biological samples in low abundance. 1, 9-11, 18, 20 
1.2.7 Principle of post-source decay (PSD)  
In addition to performing an MS1 experiment on MALDI-TOF, tandem mass 
13 
spectrometry (MS2) is also possible with a MALDI-TOF reflectron mass analyzer. 
This process can be accomplished with post-source decay (PSD), in which the ions 
formed in the ion source undergo the metastable dissociation in the field free drift 
region, which is located between the ionization source and the reflectron device; see 
Figure 6.18, 19, 21 The generated charged fragments possess the same velocities but 
different kinetic energies with the precursor ions. Thus these fragments can be 
detected in the reflectron TOF analyzer which has the capability of distinguishing the 
ions with different kinetic energies. Consequently, a reflectron can be used as a 
tandem mass spectrometry to detect the ions produced in the metastable 
fragmentation to obtain the structural information of the ion of interest.18, 19, 21 
In PSD technique, a series of electrodes (precursor ion selector) are located 
after the ionization source, along the ion flight path, as shown in Figure 6. A potential 
is applied continuously to deflect ions. For instance, if the ions generated from the 
ionization source retain positive charges, a negative potential is applied on the 
precursor ion selector to eliminate the ions. This potential is active all the time except 
for a short of period when the selected precursor ion is passing by. The selected 
precursor ion undergoes metastable dissociation in the field free drift region and 
generates both neutral and charged product ions. A scanning spectrum is initiated 
when the neutral fragment molecules hit detector 1 (Figure 6). Since the mass of the 
precursor ion is always higher than the charged fragment ion, and both of them have 
the same velocities, the precursor ion possesses a higher kinetic energy than the 
charged fragment ions, which results in the precursor ion traveling in a longer 
pathway in the reflectron. Based on the different migration pathways, the charged 
product ions and the precursor ion are separated in the reflectron and detected by 
14 
detector 2. To facilitate metastable fragmentation of MALDI-generated ions, the PSD 
experiment is performed using a “hot” MALDI matrix (e.g. α-cyano-4-
hydroxycinnamic acid, etc). In addition, blowing air or an inert gas into the flying tube 
in the field free drift region may also enhance metastable fragmentation of the 
precursor ion.9, 18, 21  
Although PSD is useful in performing MALDI-MS/MS experiment, there are 
several limitations with this approach: poor mass resolution of the precursor ion 
selection and the inefficiency of the metastable fragmentation process, which results 
in poor quality MS/MS data, compared to other methods of MS/MS analysis.18, 19, 21 
To overcome these limitations, the tandem time of flight (TOF/TOF) instrument was 
designed to perform improved MS/MS experiments and facilitate structural analysis 
of various species.  
 
Figure 6. Schematic representation of post-source decay (PSD): the precursor ion 
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(white circle) is selected in the precursor ion selector and undergoes the metastable 
dissociation in the flying tube of field free drift region. The charged product ions 
(black circles) travel a short pathway in the reflectron than the precursor ion due to 
the lower kinetic energy and then detected by detector 2. The neutral molecules 
(black squares) strike the detector 1, which initiates the MS/MS spectrum scanning 
event. (Adapted from Edmond de Hoffmann and Vincent Stroobant, Mass 
Spectrometry principles and applications, John Wiley & Sons, Chichester, England, 
2002.)  
 
1.2.8 Principle of the tandem time of flight (TOF/TOF) mass spectrometry 
MALDI-TOF/TOF is derived from the MALDI-TOF instrument, by 
incorporating a second time of flight tube and a series of components between the 
ionization source and the electrostatic mirrors located in the reflectron at the end of 
the second flight tube; as shown in Figure 7. These components consist of timed-ion 
selector (TIS), the deceleration mirrors, a floating collision cell, a second pulsed ion 
accelerator, and a pair of deflection electrodes for metastable suppression, etc.  
Briefly, MALDI-TOF/TOF works based on the principle that the precursor ion 
is produced in the first TOF, fragmented in the collision cell, and analyzed in the 
second TOF. Specifically, the precursor ions generated in the MALDI ionization 
source are focused in the center of the TIS, which contains a double-sided deflection 
gate. The precursor ions are trapped by TIS through a time delay generator, which is 
programmed to open the gate of the TIS when the lowest mass of interest arrives to 
the gate and close the gate when the highest mass of interest passes through the 
gate. The non-selected ions are deflected away from the floating collision cell. The 
TIS-selected ions are decelerated by retarding mirrors, prior to entering the collision 
cell. In the collision induced dissociation process, the ions are activated and collided 
by the collision gas (N2 or inert gas) with selected energy, which can be varied by 
16 
 
Figure 7. Schematic representation of MALDI-TOF/TOF instrument; (Adapted from 
Marvin L. Vestal et al, Tandem time-of-flight mass spectrometry. Methods Enzymol. 
2005, 402, 79-108.) 
 
adjusting the relative potential between the ionization source and the collision cell. 
The fragment ions as well as the precursor ions exit the collision cell, pass through a 
short field free drift region and are then reaccelerated by a second pulsed ion 
accelerator into the second TOF region. Consequently, the reflectron mode in the 
second TOF region is performed to generate high resolution MS/MS spectra. The 
metastable suppressor consisting of a set of deflection electrodes is used to deplete 
the “metastable” ions, which are produced outside of the collision cell, thus, 
improving the quality of the MS/MS spectra.4, 10, 18, 20  
Aside from performing MS2 experiments on MALDI-TOF/TOF instrument, the 
linear and reflectron modes in the MS1 experiment can also be performed in the 
MALDI-TOF/TOF system without applying any voltages on the components added 
between ionization source and electrostatic mirrors for the MS2 experiment. The 
performance of a MALDI-TOF/TOF system in MS1 experiments in linear mode and 
reflectron mode is the same as the MALDI-TOF instrument described in the previous 
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sections, 1.2.4 and 1.2.6, respectively.4, 18, 20 
 
1.3 Electrospray ionization (ESI)   
In addition to the MALDI ionization process, ESI is the softest ionization 
source that has been applied in the analysis of non-volatile biological samples, such 
as proteins, glycoproteins, carbohydrates, and peptides, etc. In this ionization 
process, the analytes are transferred from the solution phase to the gas phase via a 
metal capillary, to which a high voltage (from ~ 700 V to 5 KV) is applied; see Figure 
8.19 The liquid sample is infused through the capillary, which disperses the liquid 
solution into a mist of small, charged droplets. If a positive voltage is applied on the 
capillary, positively charged droplets are formed. The solvent on the positively 
charged droplets are evaporated by applying drying gas, heat or both, at 
atmospheric pressure.19 As the solvent evaporates, the positively charged droplets 
shrink in size, and the charge density on their surface increases until it reaches the 
Raleigh limit, in which the repulsive Columbic forces between ions within the droplet 
exceed the surface tension of the droplets.18, 19, 21 This causes fission of the droplets 
to form smaller charged droplets. As the solvent on the smaller droplets continues to 
be evaporated, the charged droplets keep breaking down into the smaller droplets 
and ultimately become a single ion.21 This process is called Coulomb fission.2, 13, 15, 24 
Another proposed mechanism for ion formation is ion evaporation, in which the 
charged droplets become smaller by releasing one charged ion at a time, until the 
whole droplet contains one charged solute molecule in it. The produced charged ions 
from the ionization process are electrostatically directed to the mass analyzer and 
detected in the detector.2, 15, 18, 19, 24       
18 
 
Figure 8. Schematic representation of ESI ionization process; the ions are 
transferred from liquid phase to gas phase via two mechanisms: (A) Coulomb fission 
and (B) Ion evaporation. (Adapted from Chhabil Dass, Fundamentals of 
Contemporary Mass Spectrometry, Wiley-interscience, New York, 2007.) 
 
 
1.4 Principle of quadrupole ion-trap mass spectrometry  
The quadrupole ion-trap (QIT) mass analyzer was invented in 1958 by 
Wolfgong Paul and his colleagues.18, 19, 21 Since then, it has been utilized in a 
diversity of applications ranging from small compounds (e.g. drug metabolites, 
pharmaceuticals, etc) to large biologically relevant molecules, such as proteins, 
peptides, and their corresponding modifications, etc.19  
Typically, the quadrupole ion trap consists of a ring electrode and two endcap 
electrodes; See Figure 9.18 Mass separation in this instrument is accomplished by 
storing the ions in the trapping space, and ejecting one m/z at a time through small 
holes in the exit endcap, to a detector, by oscillating electric field created within the 
three electrodes.18 Specifically, the ions created in the ionization source (e.g. ESI, 
MALDI, etc) are electrostatically drawn into the analyzer and trapped in a three-
dimentional quadrupole filed, which is created by applying a voltage Φ0 (Equation 
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1.7) to the ring electrode and maintaining the endcap electrodes at ground 
potential.18  
                                                 Φ0=U-Vcosωt                                                   (1.7) 
Where U is the amplitudes of the dc (constant) voltages and V is the amplitude of rf 
(alternating) voltages; ω is the angular frequency. A potential well is formed within 
the boundaries of the electrodes, and the lowest potential point of this well is located 
in the center of the trap. Once the ions enter the quadrupole field, the helium gas (at 
a pressure of 1mtorr) which is present in the trap is utilized to cool the kinetic 
energies of these ions and confine them in the center.18 After the ions are focused in 
the center of the trap, a gradually increased rf voltage is applied on the ring electrode 
to eject the ions from the trap for detection. During this process, all the trapped ions 
migrate in a figure eight-shaped pathway; See Figure 9. The large m/z(s) migrate in 
a bigger pathway with a lower frequency, while the small m/z(s) migrate in a smaller 
pathway with a higher frequency. According to Equation 1.8,  
                                                 m/z = 4eV/(qmaxω2r02)                                             (1.8) 
where qmax is 0.908, and r0 is the radius of the trap, under a given rf voltage (V), all 
the ions above a certain m/z value can be restored within the quadrupole field and 
the ions lower than this value become unstable and are ejected out from the trap.18 
Accordingly, as ramping the rf voltage V, the ions of sequentially increasing m/z are 
forced to be unstable, and ejected out from the ion trap for external detection.18, 21 
This approach of ejecting ions is known as “mass-selective instability mode”.18 The 
alternative approach to eject ions is the “resonance ion ejection”, in which a 
supplementary rf voltage is applied to the endcap electrodes to eject ions with 
different m/z(s).18  
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In addition to performing MS1 experiment, MS/MS (or MSn) experiments are 
also performed in the QIT. In this process, all the ions but the m/z(s) of interest are 
ejected and a rf voltage is applied to the endcap electrode to excite the ions of 
interest, thus, facilitates generating fragmentation ions.18, 21 The produced fragment 
ions as well as the precursor ions are then ejected from the QIT for external 
detection.  
One salient feature of quadrupole ion trap is that it can perform multiple 
collision-induced dissociation experiments (CID) without requiring multiple 
analyzers.19 Other predominant features of QIT instrument include its compact 
instrument size, and its capability to accumulate ions, thereby, enhances the signal-
to-noise (S/N) in an analysis.19 
 
Figure 9. Schematic representation of quadrupole ion trap mass spectrometer. 
(Adapted from Chhabil Dass, Fundamentals of Contemporary Mass Spectrometry, 
Wiley-interscience, New York, 2007.) 
 
 
1.5 Principle of Fourier transform mass spectrometry 
Aside from the quadrupole ion trap, Fourier transform ion cyclotron 
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resonance mass spectrometry (FTICR-MS) is another technique which works 
based on the same principle of trapping ions. This instrument was invented in 1974 
by Comisarow and Marshall.18, 21 Since then, it has been widely used for the 
analysis of numerous species with the highest mass resolution and mass accuracy, 
compare to other mass analyzers.19 
The key component of this instrument is a mass analyzer cell, which is 
housed inside a strong magnetic field.18 This cubic cell consists of three pairs of 
electrodes, including two trapping plates (front and back electrodes), two excitation 
plates (the side electrodes), and two receiver plates (the top and bottom 
electrodes); See Figure 10.18 The generated ions from the ionization source enter 
the analyzer cell along the same direction (z-axis) as the magnetic field, and they 
are confined to the center of the cell by applying a small voltage with the same 
polarity of the ions on the trapping plates. Prior to excitation, the trapped ions 
migrate along the z-axis at different frequencies, depending on their m/z values.18 
To excite and detect these trapped ions, the remaining four plates in the cell are 
utilized. In the excitation process, a range of radio frequency (rf) is applied to the 
two excitation plates. The ions absorb energy, which causes their cyclotron radius 
to enlarge and become coherent; therefore, the isomass ions cycle coherently at 
the same orbital radius.18, 21 As the ions pass by the two receiver plates, an image 
current induced by the ions is detected as a function of time and Fourier 
transformed to the frequency domain to generate a mass spectrum.18, 21 The 
generated image current oscillates at the same frequency as the coherently 
migrating ions, which relies on their m/z values. Since the ions are continuously 
migrating in a coherent circular pathway, they can be re-measured numerous 
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times, and this enhances the sensitivity and resolution of the instrument.  
 
Figure 10. Schematic representation of Fourier transform ion cyclotron resonance 
mass spectrometry (FTICR-MS). (Adapted from Chhabil Dass, Fundamentals of 
Contemporary Mass Spectrometry, Wiley-interscience, New York, 2007.) 
 
1.6 Background information on carbohydrates and glycoproteins 
Carbohydrates are the most abundant and structurally complex species 
present in nature.12, 13, 24-28 They are comprised of mono-, oligo-, and polymeric 
saccharides. In oligo-, and polysaccharides, branched structures can form, due to 
the different linkages that could be potentially present in the constituent 
monosaccharides; thereby, this results in a very large structural diversity in 
carbohydrates.12, 13, 24 In addition to the complexity in the linkages among 
monosaccharides, carbohydrates can also be modified by addition of acidic 
functional groups to form sialylated, sulfated, or phosphorylated species. These 
acidic functional groups on carbohydrates influence their biological functional roles. 
Specifically, sialylation is involved in controlling the half-life circulation time and 
receptor binding.29, 30 Sulfation is linked to biological recognition, and protein 
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clearance.31 Alteration in phosphorylation of a carbohydrate correlates to diverse 
types of diseases, and the phosphorylation state of certain carbohydrates can be 
used as prognostic markers for breast cancer, ovarian cancer, and prostate cancer, 
etc.32, 33 
Carbohydrates attach to proteins to generate either O-linked or N-linked 
glycoproteins. In O-linked glycosylation, the glycans are anchored via a hydroxyl 
oxygen of serine(S) / threonine (T) to form a glycosidic bond. In N-linked 
glycosylation, the carbohydrate is linked via an amide bond attached to the 
asparagine (N) sidechain. The asparagine must be present in the consensus 
sequence N X T/S, in which X can be any amino acid residues except for proline.13 
All the N-linked glycans contain a common trimannosyl chitobiose core consisting of 
[HexNAc2+Hexose3], which is boxed in scheme1.13-16 Based on the differences in the 
outer branches of the glycans, the  
 
N-linked glycans can be classified as high mannose, hybrid and complex types.13-16 
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The research presented in this manuscript focuses on the N-linked glycoproteins, 
since these proteins are the most abundant species in mammalian cells.13  
Glycosylation on proteins affects various biological functions of the proteins 
(e.g. protein binding, inter- or intra- cell signaling, etc),28, 34-43 and it can serve as an 
indicator of disease.34-38, 44-47 For example, human serum glycoproteins, 
immunoglobulin G (IgG), transferrin, and α1-acid glycoprotein (AGP) are the most 
abundant and significant proteins in human plasma. Human IgG is the major 
immunoglobulin in human serum and serves as antibody. The neutral glycans on 
human IgG are involved in inter-/intra cell signaling. Transferrin is a metal carrying 
serum protein, transporting iron to tissues, via the circulation system.48 Alteration in 
the glycosylation pattern on this protein affects iron homeostasis in the body. AGP, 
also known as orosomucoid, is one of the important positive acute phase proteins in 
human plasma.44 Although the biological functions of AGP are not fully understood, 
changes in the glycosylation in some pathological conditions have been implicated, 
such as chronic inflammation, pregnancy, etc.44 In addition, AGP has affinity for 
various basic or neutral lipophilic drugs from endo and exogeneous sources,49-51 and 
these binding activities largely rely on the glycan structures. Therefore, 
characterization of the glycosylation in proteins is one important step in developing a 
comprehensive understanding of the biological significance of glycosylation and in 
facilitating disease diagnosis. Aside from human serum glycoproteins, several other 
glycoproteins, such as glycoprotein hormones,52 and HIV Env proteins (CONS gp140 
∆CFI and JRFL gp140 ∆CF) 53 are also used in this study for glycan analysis by 
mass spectrometry.   
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1.7 Analyzing carbohydrates and glycoproteins by mass spectrometry 
There are two basic approaches to characterizing glycans on glycoproteins 
by mass spectrometry, either cleaving of the glycans or analyzing glycopeptides; see 
Figure 11.14-17, 54 For glycan analysis, the glycans are enzymatically or chemically 
released from the protein, followed by a separation technique and then detected by 
MS. Since the glycans ionize inefficiently, the reducing-terminus of the glycans is 
frequently derivatized in a reductive amination reaction by an aromatic amine; this 
facilitates detection of the glycans in mass spectrometry.17 Although this approach is 
useful in characterization of glycans with high sensitivity, the glycosylation site-
specific information, which defines where on the protein the glycans are attached can 
not be elucidated, unless the glycosylation sites are separated prior to glycan 
release.31  
 
Figure 11. Schematic representation of characterization of glycans on glycoproteins 
by mass spectrometry: circle: glycans; star:derivatized reducing ends on the glycans.  
 
The alternative approach to characterizing glycans on glycoproteins is to 
perform glycopeptide-based analysis, in which the glycans and their attached 
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glycosylation sites can be elucidated in the same experiment. This affords 
glycosylation site-specific information, which is useful in elucidating the functional 
properties of glycoproteins.31, 55 Typically, the glycopeptide-based analysis entails 
enzymatic digestion by either specific or non-specific proteases, followed by a 
separation approach (e.g. high-performance liquid chromatography, etc) and then 
mass analysis. One salient feature of this approach is that the peptide portion in the 
glycopeptides is more readily ionized than underivatized glycans; so no extra 
derivatization step is needed.17 As a result, this approach can be used for elucidation 
of glycan structures on proteins with relatively low detection limits.17 
In addition to the advantages of using glycopeptide-based MS analysis, 
several challenges are encountered in this approach, including sample preparation 
and data analysis.54 For sample preparation, due to the presence of glycans on 
glycopeptides and their high degree of heterogeneity, the mass spectral signals of 
glycopeptides are suppressed by the strongly ionizing peptides when both species 
co-exist in a complex mixture. Therefore, the enrichment/separation process is 
critical in the sample preparation of glycopeptide analysis. Detailed information for 
the comparison of different enrichment and/or chromatographic approaches is 
discussed in Chapter IV.  
For data analysis, two “unknowns” are generated from glycopeptide-based 
analysis, the glycan moiety and the peptide moiety of a glycopeptide peak in the 
mass spectrum. This is due to the heterogeneity in both glycosylation and peptide 
potion of the glycopeptides generated in enzymatic digestion. In order to 
unambiguously assign the glycan compositions for the glycopeptides, the peptide 
must be identified first. Knowledge of the primary sequence of the protein is required 
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to generate the theoretical peptide masses, which are necessary for elucidating the 
peptide moiety of the glycopeptides.17 This process of identifying the peptide 
composition can be accomplished by a web-based tool GlycoPep ID developed by 
our group. After identifying composition of the peptide moiety of glycopeptides, the 
process of assigning the glycan compositions of glycopeptides to MS1 data is greatly 
facilitated. The detailed steps of data analysis in glycopeptide-based analysis can be 
found in reference [50] and [51].56, 57 
1.8 Overview and summary of the following chapters 
The research presented herein focuses on developing several efficient MS-
based approaches to characterize post-translational modifications on glycoproteins. 
These approaches include ion-pairing strategy in conjunction with ESI-MS/MS to 
identify the acidic functional groups (sulfate, and phosphate) in carbohydrates and 
glycopeptides; (Chapter II, III) and a glycopeptide-based MALDI-TOF/TOF approach 
to characterize glycans on different glycoproteins varying in the number of 
glycosylation sites and their corresponding glycan profiles (Chapter IV).  
In addition to glycosylation, disulfide connectivity is another important protein 
modification, and it plays a key role in establishing/maintaining protein structures in 
their biologically active forms. Therefore, the determination of disulfide bond 
arrangement will provide an efficient way to obtain the chemical structural 
information about proteins, and these studies may lead to insights into the proteins’ 
functional roles. Towards this end, a mass spectrometric approach using liquid 
chromatography followed by eletrospray ionization-Fourier transform ion cyclotron 
resonance mass spectrometry (LC/ESI-FTICR-MS) was developed to determine the 
disulfide bond arrangement in proteins and glycoproteins, as described in Chapter V. 
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The content of each chapter in this manuscript is summarized below. 
1.8.1 Using ion-pairing strategy to differentiate between phosphorylation and 
sulfation in mass spectrometry. (Chapter II and III) 
The studies presented in Chapter II and III focus on the discrimination of 
sulfation from phosphorylation in mass spectrometry. Phosphorylation and sulfation 
are two important biological modifications present in carbohydrates, proteins, and 
glycoproteins. Typically, sulfation and phosphorylation cause different biological 
responses, so identification of these two functional groups is important for 
understanding structure/function relationships in various species. Mass spectrometry 
is one of the methods used to detect the presence of these two modifications in 
complex biological mixtures. However, phosphorylated and sulfated structures are 
isobaric; thus, differentiation between them in routinely used mass spectrometers is 
not possible. To overcome this problem, a novel mass spectrometric method, ion-
pairing, in conjunction with ESI-MS/MS analysis, is developed on model 
phosphorylated/sulfated carbohydrates(Chapter II), and subsequently applied in 
discriminating sulfation from phosphorylation present in other biologically relevant 
molecules, including mono-, di-, saccharides, and the highly sulfated glycoprotein, 
ovine luteinizing hormone; see Chapter III. The ion-pairing strategy developed herein 
is the first study demonstrating that this robust approach can be used to differentiate 
the two isobaric functional groups, and this method is also useful in the detection of 
phosphorylated compounds in complex mixtures.32, 33  
1.8.2 Method development in glycan profiling on glycoproteins. (Chapter IV) 
The research presented in Chapter IV focuses on method development for 
characterization of N-linked glycans on glycoproteins, to facilitate understanding how 
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the glycan structures influence biological functional roles of glycoproteins. To date, 
glycopeptide-based MS analysis has proven to be a well-suited approach for 
characterizing glycans, since the glycan and its attachment site on the protein can be 
elucidated in the same experiment. However, when glycopeptides co-exist with 
peptides, glycopeptide signals are usually suppressed by the strongly ionizing 
peptides. Towards this end, it would be desirable to seek methods to improve 
glycopeptide detection. In Chapter IV, we performed an in-depth study of maximizing 
glycosylation coverage on model glycoproteins by optimizing all the aspects of 
glycopeptide-based analysis, including sample preparation methods, mass spectral 
techniques, and data analysis strategies. In doing so, we created a work-flow that is 
designed specifically to optimize the coverage of glycosylation heterogeneity in terms 
of the number of glycosylation sites detected and their corresponding glycan profiles. 
To test the effectiveness of this approach, a glycoprotein with 27 potential 
glycosylation sites was analyzed. This work demonstrates that our strategies 
significantly improve the glycopeptide detection to elucidate a variety of glycoforms 
present on proteins, thereby, facilitating the understanding of the functional 
properties of glycans on glycoproteins.  
1.8.3 Method development in determination of disulfide bonds on 
glycoproteins. (Chapter V) 
In addition to glycan profiling on the glycoproteins, determining the disulfide 
bonding pattern is another important feature in protein structural analysis. In Chapter 
V, aiming to understand how the HIV Env protein’s structure influences its 
immunogenicity, we developed a highly efficient MS-based approach, liquid 
chromatography electrospray ionization Fourier transform ion cyclotron (LC/ESI-
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FTICR) mass spectrometry, to determine the disulfide linkages on a synthetic form of 
the HIV Env protein, CON-S gp140 ∆CFI, which has marked improvement in 
antigenicity, compared to other similar wild-type proteins. This study is the first 
investigation of utilizing mass spectrometry to determine the disulfide bonding 
pattern in the HIV Env protein. The disulfide bonding pattern obtained from this study 
complements the glycan profiling (also performed in our lab) to reveal overall 
structural information, including functional domains and glycan shields present on 
CON-S gp140 ∆CFI. Thus, these studies may provide beneficial information for 
understanding the immunogenetic activity of this protein, which would lead to insights 
to guide the direction of future vaccine development. 
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Chapter II 
 
A novel mass spectrometric method to distinguish isobaric monosaccharides 
that are phosphorylated or sulfated using ion-pairing regents 
 
Reprinted by permission of Elsevier Science from “A novel mass spectrometric 
method to distinguish isobaric monosaccharides that are phosphorylated or sulfated 
using ion-pairing reagents” by Zhang, Y.; Go, E.P.; Jiang, H.; Desaire, H. Journal of 
American Society for Mass Spectrometry, Vol 16, pp1827-1839, copyright © 2005 by 
the American Society for Mass Spectrometry. 
 
 
2.1 Introduction: 
 
Phosphorylation and sulfation are functionally significant biological 
modifications commonly found in metabolites, carbohydrates, proteins, and 
glycoproteins. Phosphorylation is linked to signal transduction, gene expression, cell 
cycle, cytoskeletal regulation, and apoptosis [1-8]. In particular, phosphorylated 
carbohydrates are integral components of nucleic acids [1,5], oligosaccharides [1,5], 
glycopeptides [2,3,4,6], and glycoproteins [2-4]. They are also involved in glycolysis 
processes in the extracellular matrix [7,8]. Sulfation effects protein recognition and 
helps facilitate clearance of proteins and metabolites from the body [9-14]. 
Specifically, sulfated carbohydrates represent a class of biologically active and 
pharmaceutically important molecules [10]. They are essential in neuropathology and 
used as therapeutic agents [9]. Because phosphorylation and sulfation have been 
linked to different biological functions, differentiating these structures is essential for 
understanding structure/function relationships in proteins, carbohydrates, and 
metabolites.  
 Numerous studies [1-4, 6-7, 9-18] have been utilized to characterize the 
phosphorylation and sulfation. These methods indicate that selective and sensitive 
detection of phosphorylated and sulfated compounds in complex matrices is 
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paramount. Radiolabelling [3,6,11-14] is one of the commonly used methods to 
identify phosphorylated and sulfated carbohydrates with good specificity. While this 
method is hazardous and time-consuming, phosphorylated or sulfated species can 
be selectively discriminated in the presence of many other compounds in the matrix, 
using radiolabeling.  
Mass spectrometry, which is highly selective and sensitive, could possibly 
provide information about phosphorylation and sulfation without the need for 
radiolabelling [3,15-17]. Recent MS experiments to identify phosphorylated 
compounds include exact mass differentiation [2] and discrimination using ion-
molecule reactions [1] by using Fourier Transform Ion Cyclotron Resonance Mass 
Spectrometry (FTICR-MS). While these two methods are useful in differentiating the 
presence of phosphorylated and sulfated compounds, only a few groups have 
access to these sophisticated instruments. Thus, developing the mass spectrometric 
methods on more readily available instruments will benefit investigators who are 
interested in this field.  
Herein, we utilize basic peptides [9,19-23] as ion-pairing reagents to complex 
to phosphorylated or sulfated carbohydrates via non-covalent interactions [9,19-23] 
and perform MS/MS experiments on each complex to obtain the structural 
information. This is the same ion-pairing technique employed in MALDI and ESI that 
is used to enhance the signal of sulfated carbohydrates [19, 20]. Since both 
phosphate and sulfate are highly acidic compounds with different proton affinities, 
differences in their chemical reactivities with the ion-pairing reagents may be used to 
distinguish their structures by MS/MS experiments. This is the first study to illustrate 
that ion-pairing can be used in conjunction with MS/MS to differentiate isobaric 
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phosphorylated and sulfated compounds. In addition to its application to simple 
carbohydrates, this method is also potentially applicable in identifying 
phosphorylation and sulfation in glycosaminoglycans and glycoproteins in biological 
samples.  
This work complements other mass spectrometric studies that have 
discriminated phosphorylation from sulfation using FTICR-MS [1,2], and most 
recently MALDI-MS in which the differentiation was accomplished by monitoring the 
differences in the ionization behavior between the two functional groups [24]. In 
addition to discriminating these isobars, ion pairing has the added advantage of 
simultaneously enhancing the mass spectral signal of these acidic groups, even 
when they are present in complex mixtures of other compounds [20]. 
 
2.2 Experimental Section 
Chemicals and Materials 
All of the phosphorylated and sulfated monosaccharides and peptides were 
purchased from Sigma-Aldrich (St. Louis, MO), except for the three basic peptides 
Arg-Arg-Arg (R3),  Arg-Ser-Lys (RSK) and Arg-Gly-Lys (RGK). These three small 
peptides were synthesized at the University of Kansas Biological Research Service 
Laboratory using solid phase peptide synthesis. All chemicals were used without 
further purification and all solvents were HPLC grade. 
Sample Preparation 
 All of the compounds including basic peptides were dissolved in a minimal 
amount of HPLC grade water. Peptide stock solutions were further diluted with 
methanol : water (MeOH:H2O) mixture (1:1) containing 0.5% acetic acid, to a final 
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concentration of 2 mM. All phosphorylated and sulfated monosaccharides were 
diluted to 1 mM. Prior to MS analysis, ion-pair complexes were formed by combining 
5 μL of basic peptide solution and 5 L of monosaccharides solution. The mixture 
was thoroughly mixed and 1-2 μL was directly injected into the mass spectrometer. 
Mass Spectrometry 
A surveyor MS-pump (Thermo, San Jose, CA) was used to deliver the mobile 
phase of MeOH : H2O (1:1) containing 0.5% acetic acid at a flow rate of 20 μL/min. 
1-2 L of samples were directly injected into mass spectrometer. All samples were 
analyzed on a Thermo Finnigan LCQ Advantage quadrupole ion trap mass 
spectrometer (Thermo, San Jose, CA). Electrospray ionization in both positive and 
negative ion mode was achieved by using a spray voltage of ~ 4.0 kV. Nitrogen was 
used as a nebulizing gas, at a pressure of 20 psi. A capillary temperature of 200-
230°C was maintained. Ion-pairing experiments were performed in positive ion 
mode, and MS data of the native carbohydrates was performed in negative ion 
mode.   
Collision-induced dissociation (CID) was performed to obtain structural 
information. Specifically, doubly charged precursor ions were activated for 30 ms 
with 20% normalized collision energy. A qz value of 0.25 and an isolation width of 3 
Da were used. The singly charged precursor ions were activated with 15% 
normalized collision energy.  
 
2.3 Results and Discussion 
MS data for isobaric monosaccharides without ion-pairing 
To demonstrate the effectiveness of the ion-pairing technique in 
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differentiating between phosphorylated and sulfated compounds, two sets of isobaric 
phosphorylated and sulfated monosaccharides were chosen as model compounds 
(Scheme 1). In the first set of experiments, the fragmentation characteristics of the 
isobaric monosaccharides without ion-pairing were examined. MS/MS data revealed 
that the two sets of isobaric monosaccharides, glucose-6-phosphate (Glc6P) / 
glucose-6-sulfate (Glc6S), and N-acetyl-glucosamine-6-phosphate (GlcNAc6P) / N-
acetyl-glucosamine-6-sulfate (GlcNAc6S) produce identical MS/MS data  (Figure 1A-
D).   
 
 
 
 
 
 
As a result, these isobaric monosaccharides cannot be distinguished using standard 
MS/MS methods. 
Ion-pairing for sulfated and phosphorylated carbohydrates 
To overcome this problem, ion-pairing [9,19-23] was employed for the analysis. Ten 
different basic peptides: Lys-Lys (K2), Lys-Lys-Lys (K3), Lys-Tyr-Lys (KYK), Arg-Ser-
Lys (RSK), Arg-Gly-Lys (RGK), Arg-Arg-Arg (R3), Lys-Lys-Lys-Lys (K4), Arg-Lys-
Arg-Ser-Arg-Lys-Glu (P1), Ser-Arg-Val-Ser-Arg-Arg-Ser-Arg (P2), Lys-Arg-Thr-Leu-
Arg- Arg (P3), were evaluated for their potential to form ion-pairing complexes with 
the acidic carbohydrates and facilitate their discrimination in MS/MS experiments. 
These peptides were complexed with the isobaric carbohydrates in Scheme 1. 
Glucose-6-sulfate             Glucose-6-phosphate
Glc6S                                 Glc6P
N-acetyl-glucosamine-6-sulfate
GlcNAc6S
N-acetyl-glucosamine-6-phosphate
GlcNAc6P
O
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HO
HO
O
O S O-
O
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HO
OH
O P O-
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O
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O
O
O
Scheme1. Phosphorylated and sulfated monosaccharide standards used for the ion-pairing experiments.
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Typical MS data of the carbohydrate and peptide ion-pairs depict the formation of 
abundant ion-pair complexes. An example of the carbohydrate:peptide complex 
between the phosphorylated carbohydrate, Glc6P, and the tripeptide, R3, is shown in 
Figure 2. Since the basic side chain of the peptide is easily protonated under the 
conditions used in this analysis, both doubly and singly charged ion-pair complexes 
are formed in the spectrum. This is the first example that demonstrates ion-pairing, 
which is typically used to facilitate MS detection of sulfated compounds [9,20,21], 
also can be used for phosphorylated species. Structural information on each 
carbohydrate:peptide complex was obtained from  MS/MS experiments. The data are 
presented in Table 1 and 2. To determine which peptide could be used in the 
differentiation study, the fragmentation pattern of each singly and doubly charged 
ion-pair complex was compared. The most effective ion-pairing reagents were 
identified as those that could discriminate both sets of isobaric monosaccharides, in 
Scheme 1. A summary of all the MS/MS data is in Table 1 and 2. Peptides that 
produced unique product ions for one of the isobaric compounds were deemed 
“useful”, because they could discriminate the isobars by MS/MS.  
Table 1 shows data for the singly charged complexes. Several peptides were 
ruled out as potentially useful ion-pairing candidates because their MS/MS data were 
identical for both sets of the isobaric carbohydrate:peptide ion-pairs. In fact, only the 
three peptides, R3, K3, and KYK, in Table 1, could be used to differentiate all the 
isobars in this study. The same comparison was made for the doubly charged 
complexes in Table 2. The peptides P1, P2, P3 and K3 in Table 2 were useful for 
discriminating the doubly charged isobaric complexes. Combining the results from 
both tables, indicate that K3 can be used to differentiate isobaric carbohydrates, 
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Figure 1. (-) ESI-MS/MS data for phosphorylated and sulfated carbohydrates. 
Isobaric pairs provide identical spectra. Each product ion is labeled: A) glucose-6-
phosphate (Glc6P) B) glucose-6-sulfate (Glc6S) C) N-acetyl-glucosamine-6-
phosphate (GlcNAc6P) and D) N-acetyl-glucosamine-6-sulfate (GlcNAc6S). 
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Figure 2. (+)ESI-MS data for the phosphorylated carbohydrate glucose-6-phosphate 
(Glc6P) after the addition of the ion-pairing reagent Arg-Arg-Arg (R3). The spectrum 
shows the two ion-pairs, [Glc6P+R3+2H]2+ and [Glc6P+R3+H]+. 
 
in a charge-state independent fashion. The ion-pair complexes can have different 
charge states (singly and doubly charge) in ESI. Thus, it would be beneficial if this 
method could be used to discriminate the ion-pairs in both charge states. In addition, 
being able to differentiate the isobars using two different charge states is useful 
because it provides two methods of confirming the functional groups’ assignment. To 
better understand why these isobaric complexes have different MS/MS data, the 
spectra for the phosphorylated and sulfated ion-pairs are compared. 
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Table 1: MS/MS data of singly charged complexes with different peptides
N/A: the precursor ions or product ions are not detected. +: peak detected in MS/MS. -: peak absent in MS/MS.
Peptides were ruled out based on the following criteria: (1) Data are identical for each set of the isobars. (2) The peptide 
cannot form a complex with at least one carbohydrate, so the complexes are not apparent on spectra. Bolded peptides 
are good for discriminating the isobars.
Glc6P Glc6S GlcNac6P GlcNac6S
Parent
ions
H2O
loss
Peptide Parent
ions loss
Peptide Parent
ions loss
Peptide Other Parent
ions loss
Peptide Other
peaks
P1 1219 ＋ 1219 1260 1260
P2 1263 N/A N/A N/A 1305 1203
P3 1089 1089 1130 1130
R3 747 747 788 788 687
K4 791 791 N/A N/A 832
K3 661 663 704 704
KYK 698 698 739 739
K2 535 535
RGK 620 620 661
RSK 650 650 691 691
661
576 576
N/A N/A
N/AN/AN/A N/A
796
1209
peaks
＋
－
－
＋ ＋
＋ ＋
＋
＋ ＋
＋
＋＋
＋
＋
＋＋
＋
＋
＋ ＋
＋ ＋
＋ ＋
＋ －
＋ －
＋ ＋
＋ ＋
＋ ＋
－－
＋ ＋ －
－
－
－
－
－
－
－
＋ ＋
＋ ＋
＋
＋＋
＋
＋ ＋
＋ ＋
＋ ＋
＋ ＋ －
＋ ＋
－＋
＋ ＋
－＋
－－＋
－－－
－
－
－
＋ ＋
＋ ＋
＋ ＋
[m/z] [m/z] [m/z] [m/z] [m/z] [m/z]
H2O H2O H2O
Table 2: MS/MS data of doubly charged complexes with different peptides
N/A: the precursor ions or product ions are not detected. +: peak detected in MS/MS. -: peak absent in MS/MS.
Peptides were rule out based on the following criteria: (1) Data are identical for each set of the isobars. (2) The peptide 
cannot form a complex with at least one carbohydrate, so the complexes are not apparent on spectra. Bolded peptides 
are good for discriminating the isobars.
GlcNAc6P GlcNAc6S
Parent
ions loss
Peptide Parent
ions
Peptide Other
peaks
Parent
ions
Peptide Other
peaks
Parent
ions
Peptide Other
peaks
P1 610 610 631 631
P2 633 653 653 602
P3 545 566 566
R3 374 395 395
K4 396 396 417 417531/302
K3 353302/403 403/302
284/222
KYK
K2 289 289271/161
RGK
RSK 346 346390/302 390/302
271/161
633
loss loss loss
Glc6P Glc6S
545
374
353
Other
peaks
332 403 332
261/243
350 483 350
261/243
360
261/243
390 285
276/236
N/A
242
309
326 326
261/243              
N/A N/A N/A
N/A N/A N/A N/A
N/A N/A N/A N/A
N/A N/A N/A N/A N/A N/A N/A N/A
N/AN/A
311
N/A N/A N/A N/A 370 438/302
222
＋ ＋ －
＋ ＋ －
－＋－
－＋－
＋ －－
＋ ＋
＋ ＋
＋－
＋－ ＋ ＋
＋ －－
＋ ＋ －
－＋－
＋ －－
＋ －－
＋ －
＋ ＋
＋ ＋ －
＋ ＋ 542
＋ ＋ －
－＋－
＋ －
－－
－－
＋ －
＋ －－
＋ ＋
＋ －－
＋ ＋ －
＋ －－
＋ －
＋ －
＋ －
[m/z] [m/z] [m/z] [m/z] [m/z] [m/z] [m/z] [m/z]
H2O H2O H2O H2O
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Comparison of the MS/MS data: Doubly charged complexes with K3  
The MS/MS data of the doubly charged ion-pairs of glucose-6-phosphate 
[Glc6P+K3+2H]2+ and glucose-6-sulfate [Glc6S+K3+2H]2+ are in Figure 3A and 3B. 
The product ions of the ion-pair complex, [Glc6P+K3+2H]2+, in Figure 3A include the 
singly charged K3 at m/z 403, the doubly charged K3 at m/z 202, and two ions 
corresponding to the water loss from the ion-pair complex, labeled as [M-H2O+2H]2+ 
and [M-2H2O+2H]2+, respectively. Water loss is generally expected in the MS/MS 
data of carbohydrates due to the presence of many hydroxyl groups in the 
carbohydrate’s structure [25,26]. Two other singly charged ions at m/z 261 and 243 
corresponding to the product ion, [Glc6P+H]+, and water loss from phosphorylated 
monosaccharide, respectively, were also observed. 
In Figure 3A, an ion corresponding to the protonated monosaccharide 
([Glc6P+H]+) appears in the spectrum of the phosphorylated complex, 
[Glc6P+K3+2H]2+. This ion forms when the doubly charged complex dissociates to 
two singly charged ions, [K3+H]+ at m/z 403 and [Glc6P+H]+ at m/z 261. Doubly 
charged product ions dominate the spectrum of the sulfated complex, 
[Glc6S+K3+2H]2+. This indicates that the distribution of charges on the 
phosphorylated complex is different from that of the sulfated complex. The two 
protons on the phosphorylated complex are not exclusively located on the basic 
residue of the peptide. One of them can be transferred to the phosphate group of the 
carbohydrate. The difference in the charge distribution of the 
doubly charged sulfated and phosphorylated ion-pairs can be explained in terms of 
the proton affinities of the two functional groups. From the known pKa values of the 
sulfate (pKa=1.89) and the phosphate group (pKa=2.13) [27], it can be deduced that 
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the functional group with higher pKa has stronger proton affinity. Thus the proton 
transfer from basic residue to the mono-phosphorylated residue is more facile, 
compared to the mono-sulfated carbohydrates. Another difference in the dissociation 
between the sulfated and phosphorylated complexes is the product ion 
[K3+SO3+2H]2+ at m/z 242, which appears in Figure 3B, but not 3A.  This ion formed 
by bond cleavage between the carbohydrate and the SO3 group. The formation of 
this ion is likely due to stronger non-covalent interactions between the peptide and 
the sulfate group. Since the sulfate group has lower pKa than the phosphate group, it 
most likely complexes to the basic peptide residue more strongly. As a result, the 
covalent oxygen-sulfur bond cleaves, and the SO3 remains complexed to the ion-
pairing reagent during CID.  In contrast, the covalent phosphorus-oxygen bond does 
not cleave during CID.  Because of the differences in chemical reactivity, the 
complexes have different fragmentation patterns when they undergo the same CID 
conditions. 
Figure 3C and 3D show MS/MS data for the two other isobaric species, 
GlcNAc6P and GlcNAc6S, complexed with K3. These two ion-pair complexes can 
also be distinguished, based on their MS/MS data. In Figure 3C, two singly charged 
complementary ions [GlcNAc6P+H]+ and [K3+H]+ (m/z 302 and 403, respectively) 
originate from the precursor ion. These ions correspond to the ligand dissociation of 
the ion-pair complex. Only one other small product ion corresponding to the loss of 
water from the carbohydrate was observed, indicating that the interaction between 
phosphate and basic peptide is weaker than the covalent bonds in the 
phosphorylated monosaccharide. In addition to the two complementary ions 
observed in Fig 3C, other product ions appear in the spectrum containing GlcNAc6S  
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Figure 3. (+)ESI-MS/MS data for the doubly charged ion-pairs with Lys-Lys-Lys (K3): 
A) phosphorylated complex [Glc6P+K3+2H]2+ B) sulfated complex [Glc6S+K3+2H]2+ 
C) phosphorylated complex [GlcNAc6P+K3+2H]2+ and D) sulfated complex 
[GlcNAc6S+K3+2H]2+. 3B and 3D both show characteristic ions resulting from 
oxygen-sulfur bond cleavage. 
 
 
and K3 in Figure 3D.  These ions include water loss ions (m/z 344, 335, and 284) 
and the product ion at m/z 222, which corresponds to cleaving the oxygen-sulfur 
bond in the carbohydrate. Note that this covalent bond cleavage is only observed in 
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the MS/MS data of the sulfated carbohydrates (Figure 3B and 3D). 
 Another interesting observation in the MS/MS data in Figure 3C and 3D is 
that only the precursor and the product ions corresponding to the loss of H2O (m/z 
344 and 335, respectively) are doubly charged. All of the other product ions are 
singly charged. This fragmentation behavior is different than the MS/MS data of the 
ion-pair complexes shown in Figure 3A and 3B. This must be due to the type of 
carbohydrate complexed with the peptide. Hence, in addition to proton affinities, the 
type of carbohydrate is another important factor that can influence the ions formed in 
the CID spectra of phosphorylated and sulfated ion-pair complexes. 
Singly charged complexes with K3 
As discussed above, the MS data of the carbohydrate:peptide ion pairs show 
the formation of ion-pair complexes with different charge states: singly and doubly 
charge state complexes. MS/MS experiments were performed on the singly charged 
complexes, and the sulfated and phosphorylated monosaccharides can also be 
distinguished using these CID spectra (Figure 4). Three important ions were 
observed in the spectra: The molecular ions (MH+), the ions corresponding to water 
loss ([M-H2O+H]+), and the singly charged peptides ([K3+H]+). When identical 
collision conditions are used, the protonated peptide K3 at m/z 403 in Figure 4 is 
observed upon CID in the MS/MS data of the phosphorylated complex, but not in that 
of the sulfated complex. The presence of these singly charged peptide product ions 
[K3+H]+ provides additional evidence that phosphorylated ion-pair complexes are 
weaker than the sulfated ion-pair complexes, because the sulfated complexes 
undergo the covalent cleavage only (loss of H2O), while the phosphorylated 
complexes undergo cleavage of the non-covalent interaction. This method of 
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differentiating the isobars is dependent on the collision energy used. At higher 
collision energies, the sulfated complexes also undergo ligand dissociation. 
 
 
 
Figure 4. (+)ESI-MS/MS data for singly charged complexes with Lys-Lys-Lys (K3) to 
identify the difference in chemical reactivity between phosphate and sulfate of the 
following carbohydrate:peptide complexes: A) phosphorylated ion-pair complex 
[Glc6P+K3+H]+, B) sulfated ion-pair complex [Glc6S+K3+H]+, C) phosphorylated ion-
pair complex [GlcNAc6P+K3+H]+, and D) sulfated ion-pair complex 
[GlcNAc6S+K3+H]+. 
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Application to other phosphorylated and sulfated monosaccharides 
The ion-pairs with different charge states have different fragmentation characteristics 
based on the observations discussed above. Doubly charged sulfated compounds produce 
ions that correspond to cleavage of the oxygen-sulfur bond, resulting in losses of SO3 in the 
MS/MS data, while phosphorylated compounds are more likely to undergo ligand 
dissociation to produce the protonated carbohydrates, instead of covalent bond cleavages. 
When singly charged ion-pair complexes undergo CID, the dissociation of the non-covalent 
complex occurs more readily for the phosphorylated compounds. This results in formation of 
the product ions [K3+H]+ in the CID data of the phosphorylated complexes. To test whether 
the chemical reactivity trends observed for the four isobaric monosaccharides are conserved 
when slight changes in the monosaccharides occur, the ion pairing MS/MS experiments 
were applied to other commercially available phosphorylated and sulfated monosaccharides. 
The structures of the monosaccharides shown in Scheme 2 include N-acetyl-
glucosamine-1-phosphate (GlcNAc1P), N-acetyl-galactosamine-4-sulfate 
(GalNAc4S), glucose-3-sulfate (Glc3S) and isomers α-glucose-1-phosphate 
(αGlc1P), β-glucose-1-phosphate (βGlc1P). MS/MS data of the doubly charged ion-
pair complexes of the sulfated and phosphorylated carbohydrates complexed with K3 
are shown in Figure 5. Figure 5A and 5B are two phosphorylated isomers α-Glc1P 
and β-Glc1P complexed with K3, while the two N-acetylhexosamine:peptide ion pairs 
[GlcNAc1P+K3+2H]2+ and [GalNAc4S+K3+2H]2+ are shown in Figure 5D and 5E. 
The two N-acetylhexosamines are readily distinguished in this experiment. 
Two complementary ions: protonated hexosamine [GlcNAc1P+H]+ (m/z 302) and 
peptide ion [K3+H]+ (m/z 403) are shown in Figure 5D, which is consistent with the 
trends of dissociation of phosphorylated ion pairs upon CID. The ion (m/z 204) is 
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most likely a secondary product resulting from the fragmentation of the ion at m/z 
302. In Figure 5E the product ion corresponding to the cleavage of the oxygen-sulfur 
bond is labeled at m/z 222 which corresponds to [GalNAc4S-SO3+H]+. This ion 
clearly indicates that the monosaccharide is sulfated and not phosphorylated.  
 
 
 
 
 
 
 
 
 
 
 
The data for the hexose monosaccharides is also consistent with the trends 
established for the CID spectra of the isobaric monosaccharides in Figure 3. Two 
product ions (m/z 261 and m/z 403) originating from the ligand dissociation are 
apparent in the spectra of phosphorylated complexes [αGlc1P+K3+2H]2+, Figure 5A 
and [βGlc1P+K3+2H]2+, Figure 5B. The product ion at m/z 242 corresponding to the 
oxygen-sulfur bond cleavage appears in Figure 5C. However, these three 
characteristic product ions that are useful to discriminate the hexoses are not present 
in abundance. To further verify the different fragmentation characteristics of both 
phosphorylated and sulfated hexoses:peptide ion-pair complexes upon collisional 
Scheme 2. Structures of other phosphorylated and sulfated monosaccharides used for the 
ion-pairing experiments.
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activation, peptide KYK was introduced in the analysis.  
Figure 6 shows the MS/MS data of the doubly charged hexoses:peptide ion-
pairs. The observed difference between the MS/MS data of the ion-pair complexes in 
Figure 6A and 6B, which are model isobaric molecules, are consistent with the 
trends discussed above. Two complementary product ions at m/z 260.9 and m/z 
438.3 are originating from the ligand dissociation in Figure 6A. While an ion 
corresponding to oxygen-sulfur bond cleavage appears in Figure 6B, along with 
many other product ions resulting from the covalent bond cleavages. This 
demonstrates that peptide KYK is useful to distinguish doubly charged 
hexoses:peptide ion pairs. From the other spectra in Figure 6, the relative 
abundance of the ions corresponding to the non-covalent cleavage in 
phosphorylated complexes (ions at m/z 260.9 and m/z 438.1 in Fig. 6C and 6D) and 
oxygen-sulfur cleavage in sulfated complexes (ion at m/z 309.4 in Fig. 6E) are 
enhanced when KYK is used as the ion-pairing reagent, instead of K3. This peptide 
provides the complementary information to confirm the fragmentation characteristics 
of hexoses:peptide ion pairs. To summarize, the peptide K3 was useful at 
distinguishing the monosaccharides, but the important, discriminating ions were in 
low abundance.  The identity of each of the monosaccharides could be further 
supported using another peptide that discriminated the hexoses, KYK.  
Aside from the doubly charged ion pairs, the CID data of the singly charged ion pairs 
are summarized in Table 3. Upon collisional activation, the singly charged 
phosphorylated ion-pair complexes dissociate to produce the abundant peptide 
[K3+H]+. This ion is useful to distinguish phosphorylated and sulfated complexes. 
These results are consistent with the MS/MS data for the original four isobaric 
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monosaccharides, in Figure 4.Using the singly charged complexes to differentiate 
the hexose monosaccharides represents a third successful approach to identifying 
the chemical composition of these monosaccharides. Clearly, the ion pairing strategy 
is robust in that it is useful under many conditions, for various types of 
monosaccharides, various charge states, and various ion-pairing reagents. These 
data also demonstrate that the rules developed to describe the dissociation of the 
isobaric monosaccharides could be applied to any other sulfated or phosphorylated 
monosaccharide. Since these rules appear to be functional group specific, and not 
compound specific, it is quite plausible that these principles could be extended to 
larger oligosaccharides or glycopeptides. Overall, the comparison of the MS/MS data 
of both abundant ion-pairs demonstrates that ion-pairing reagents, K3 and KYK, can 
be used to effectively distinguish phosphorylated and sulfated compounds in terms of 
their fragmentation characteristics in the CID spectra.   
While differentiating positional isomers is not the subject of this investigation, 
ion-pairing may also be useful for identifying the location of the phosphate on the 
monosaccharides. A unique product ion is present in Figures 5 and 6 for the 
monosaccharides phosphorylated at the anomeric carbon. This product ion 
corresponds to cleavage of H3PO4 from the monosaccharides. When the phosphate 
is at the C6 position, a loss of H2O is observed instead. A possible explanation for 
this behavior is that the water loss from Glc6P and GlcNAc6P is coming from the 
hydroxyl group of C1. Once the hydroxyl group is replaced by the phosphate group, 
a carbohydrate/phosphate cleavage occurs instead. This hypothesis is also 
supported by the observation that the complexes produced from Glc1P or GlcNAc1P 
do not have water loss product ions in their CID spectra. 
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Figure 5. (+)ESI-MS/MS data for the doubly charged ion-pair complexes with the 
tripeptide Lys-Lys-Lys (K3) verifying which species were sulfated or phosphorylated 
of the following carbohydrate:peptide complexes: A) phosphorylated complex 
[αGlc1P+K3+2H]2+, B) phosphorylated complex [βGlc1P+K3+2H]2+, C) sulfated 
complex [Glc3S+K3+2H]2+, D) phosphorylated complex [GlcNAc1P+K3+2H]2+, and 
E) sulfated complex [GalNAc4S+K3+2H]2+. 5C and 5E both show characteristic ions 
resulting from oxygen-sulfur bond cleavage. 
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Figure 6. (+)ESI-MS/MS data for the doubly charged ion-pair complexes with Lys-
Tyr-Lys (KYK) A) phosphorylated complex [Glc6P+KYK+2H]2+  and B) sulfated 
complex [Glc6S+KYK+2H]2+ C) phosphorylated complex [αGlc1P+KYK+2H]2+, D) 
phosphorylated complex [βGlc1P+KYK+2H]2+ , and E) sulfated complex 
[Glc3S+KYK+2H]2+.  
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Potential application to biological samples 
Phosphorylation and sulfation of glycoprotein and glycopeptides are involved 
in a variety of significant biological functions. Differentiation between these species is 
crucial in the characterization of structure/function relationship of modified 
glycoprotein or glycopeptides. As discussed above, the peptides, K3 and KYK, are 
effective ion-pairing reagents to distinguish phosphorylated and sulfated 
carbohydrates. Since KYK cannot readily form the complexes with some 
monosaccharides, K3 is a potential ion-pairing reagent that can be used to 
distinguish sulfate and phosphate biological systems. In a previous study, K3 has 
been utilized to complex with mono- and di-sulfated glycopeptides to enhance the 
signal in the positive ion mode of ESI-MS and provide structural information about 
the sulfated glycopeptides [20]. Also, the results presented herein indicate that the 
Table 3: MS/MS data of singly charged complexes with K3
[HexNAcs+K3]+ [Hexoses+K3]+
HexNAcs Hexoses
[K3+H]+[K3+H]+ Parent IonsParent Ions
GlcNAc6P
GlcNAc1P
GlcNAc6S
GlcNAc4S
704
704
704
704
m/z 403
(Abundance %)
m/z 403
(Abundance %)m/z m/z
Glc6P
αGlc1P
βGlc1P
Glc6S
Glc3S
663
663
663
663
663
18
N/A
N/A N/A
N/A
15
10
10
100
N/A: The product ions are not detected.
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phosphorylated carbohydrates can also complex with the ion-pairing reagents in 
good abundance in ESI-MS. This implies that K3 can potentially be applied to 
distinguish between phosphorylated and sulfated glycopeptides. A full investigation 
of the utility of ion-pairing for differentiation analysis of phosphorylated and sulfated 
glycopeptides is ongoing and will be presented separately. 
 
2.4 Conclusions 
In this manuscript all the commercially available sulfated and phosphorylated 
monosaccharides are differentiated using ion pairing and MS/MS.  Furthermore, this method 
is robust because it is effective regardless of the charge state of the ion-pair. The 
fragmentation characteristics in the CID spectra for both abundant ion-pairs were 
summarized. For doubly charged complexes, sulfated compounds are likely to undergo 
sulfur-oxygen bond cleavage, while phosphorylated compounds tend to dissociate by 
discrupting noncovalent interactions. The type of monosaccharide also affects the MS data 
of the ion pairs, but it does not affect the characteristic product ions that are useful at 
discriminating between sulfate and phosphate.  
MS/MS data of singly charged ion pairs also support the hypothesis that 
phosphorylated ion-pair complexes are weaker than the sulfated ion-pair complexes, 
because the sulfated complexes undergo covalent cleavage only, while the phosphorylated 
complexes undergo cleavage of the non-covalent interaction.   
This is the first example of using ion-pairing on phosphorylated compounds and the 
first use of ion-pairing reagents to discriminate the presence of sulfates and phosphates. 
Since we have recently demonstrated that the ion-pairing method enhances the mass 
spectral signal of sulfated glycopeptides that are minor components (<5%) of glycopeptide 
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mixtures [20], this is the only method that can simultaneously facilitate the MS detection of 
acidic species in complex mixtures and discriminate the acidic groups, sulfate and 
phosphate.  
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Chapter III 
 
Distinguishing phosphorylation and sulfation in carbohydrates and 
glycoproteins using ion-pairing and mass spectrometry 
 
Reprinted by permission of Elsevier Science from “Distinguishing phosphorylation 
and sulfation in carbohydrates and glycoproteins using ion-pairing and mass 
spectrometry” by Zhang, Y.; Jiang, H.; Go, E.P.; Desaire, H. Journal of American 
Society for Mass Spectrometry, Vol 17, pp1282-1288, copyright © 2006 by the 
American Society for Mass Spectrometry.  
 
 
3.1 Introduction 
Phosphorylation and sulfation are significant biological modifications that 
affect the functions of numerous species ─ carbohydrates,1 proteins,2-5 and 
glycoproteins.6-15 For example, tyrosine phosphorylation of proteins in the cytoplasm 
plays an essential role in intracellular signaling transduction,2,3 cell cycle control,4 
transcription of gene expression,4 cytoskeletal regulation, and apoptosis.3,4 Tyrosine 
sulfation results in different functions, including modulation of intracellular protein 
transportation, regulation of proteolytic process of proteins, and the alteration of 
biological activity of proteins.3, 5-7 Phosphorylation and sulfation present on 
carbohydrate moieties of glycoproteins also causes different biological responses. 
Changes in sulfation on the glycoproteins have been related to various diseases, 
such as diabetes, arthritis, Alzheimer’s disease, and cystic fibrosis etc.8 In addition, 
alterations in phosphorylation of carbohydrate moieties on glycoproteins are also 
linked to diverse types of diseases including the neuronal ceroid lipofuscinoses 
(NCLs) which are hereditary neurodegenerative diseases affecting human beings.9 
Moreover, phosphorylated glycoproteins, such as mannose-6-phosphorylated 
glycoprotein, can be used as prognostic markers for breast cancer, ovarian cancer, 
and prostate cancer, etc.10 Since phosphorylation and sulfation have been 
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associated with significantly different biological functions, developing efficient and 
sensitive methods to discriminate these structures is essential for understanding their 
roles in protein functions and in diseases.  
Traditionally, phosphorylation and sulfation of carbohydrates or proteins are 
detected by radiolabeling using 32P or 35S 2,6,7,14-17 isotopes, separation using gel-
filtration chromatography,11-13 high performance liquid chromatography (HPLC),11-13,16-
17 two-dimensional thin-layer chromatography (TLC),7,16 and the detection of these 
isotopes in scintillation counting or autoradiography.16 While radiolabeling is effective 
at identifying the presence of phosphorylation or sulfation, the detection step must be 
followed by additional characterization steps, since determining the presence of the 
radioisotopes does not provide any information about the structure of the compound 
that was labeled.   
In recent years, mass spectrometry has become a powerful analytical tool in 
the identification and characterization of biological molecules and their 
posttranslational modifications. It is highly sensitive and selective, and provides rapid 
means to analyze samples, obviating the need for radiolabeling.16,18 A MS-based 
method to discriminate between phosphorylation and sulfation involves reacting 
suspected phosphorylated compounds with alkaline phosphatase.16 MS analysis is 
applied before and after treatment with the enzyme to detect the loss of phosphate in 
the products.16 Although this type of enzymatic assay is effective in differentiation 
between phosphorylation and sulfation, its application is limited when analyzing 
complex mixtures, which imparts a significant barrier in many biological applications, 
especially when the compounds are phosphorylated or sulfated at low levels.16  
High resolution MS methods, such as Fourier transform ion cyclotron 
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resonance mass spectrometry (FTICR-MS), have been used to distinguish between 
phosphorylated and sulfated compounds based on their slight difference in mass19 or 
by their ability to react differently in ion-molecule reactions.20 Other MS methods, 
such as matrix-assisted laser desorption/ionization (MALDI) 21 and electrospray 
ionization (ESI),22 have been recently reported to distinguish phosphorylation and 
sulfation. In MALDI analysis, sulfated and phosphorylated products ionize somewhat 
differently, and these differences could potentially be used to distinguish phosphate 
and sulfate in an unknown compound.21 In ESI analysis, ion-pairing reagents have 
been utilized to complex with singly phosphorylated or sulfated monosaccharides.22 
The isobaric ion-pairing complexes can be differentiated in MS/MS experiments 
because of their different chemical reactivities. The fundamental study indicates that 
this approach is only functional group dependent,22 thus, it could potentially be 
effective in discriminating the phosphorylation and sulfation in larger biologically 
relevant molecules. If the ion-pairing method, which distinguishes phosphorylated 
and sulfated monosaccharides, could be adapted to larger macromolecules, like 
oligosaccharides and glycoproteins, this approach would afford a unique and 
effective way to distinguish phosphorylation from sulfation. Using ion-pairing to 
discriminate these groups is advantageous to other methods because this approach 
provides significant advantages that are not related to phosphate/sulfate 
discrimination: The ion-pairing method has already been demonstrated to enhance 
the signal of sulfated glycopeptides,23 and to facilitate structural elucidation of the 
glycan moiety present in glycoproteins.24 Thus, sulfate/phosphate determination 
could be accomplished in a synergistic analysis that also enhances sensitivity and 
provides additional structural information about glycoproteins.  
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In the work presented here, the ion-pairing approach described previously to 
discriminate monosaccharides22 is utilized to identify the phosphorylation and 
sulfation present in disaccharides and glycopeptides generated from a proteolytic 
digest of oLHα (ovine luteinizing hormone, α-subunit). Difference in chemical 
reactivities between these two acidic functional groups observed in the 
monosaccharides22 can be preserved when this approach is applied to complex 
biomolecules. This is the first study to use the ion-pairing technique in conjunction 
with MS/MS to differentiate phosphorylation and sulfation on disaccharides and 
glycopeptides. In addition to discriminating the isobaric compounds, this approach 
can also simultaneously enhance the mass spectral signal of acidic groups in 
complex mixtures by enhancing the ionization efficiency of these functional groups.23   
 
3.2 Materials and Methods 
Materials 
Phosphorylated or sulfated monosaccharides, disaccharides, and the peptide 
Lys-Lys-Lys were purchased from Sigma-Aldrich (St. Louis, MO) and were used 
without further purification. Glycopeptides from ovine luteinizing hormone, α-subunit, 
(oLHα) were produced in the laboratory of Dr. George Bousfield, Wichita State 
University, as described elsewhere.23,25  
Ion-pairing experiments 
Ion-pair complexes were formed by combining equal volumes of basic 
peptide, Lys-Lys-Lys, (henceforth referred to as K3), with solutions of 
monosaccharides or disaccharides. Phosphorylated or sulfated carbohydrates and 
K3 were dissolved in a minimal amount of HPLC grade water, respectively. 
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Carbohydrate solutions were further diluted with a methanol:water (MeOH:H2O) 
mixture (1:1) containing 0.5% acetic acid, to the final concentration of 1 mM. The 
peptide, K3, was diluted to 2 mM. Ion-pair complexes were generated by mixing 5 μL 
of carbohydrate solution with 5 μL of peptide solution, vortexing and injecting 2 μL of 
this mixture into the mass spectrometer. The ion-pair complexes of glycopeptides 
with K3 were formed by dissolving 1 μg of the glycopeptide mixture in 3 μL of a 1.25 
mM solution of K3. 1-3 μL of this sample were injected into the mass spectrometer.  
Mass spectrometry 
All the ion-pair complexes were monitored on a Thermo Finnigan LCQ 
Advantage quadrupole ion trap mass spectrometer (Thermo, San Jose, CA). A 
surveyor MS-pump (Thermo, San Jose, CA) was used to deliver the mobile phase ─ 
MeOH:H2O mixture (1:1) containing 0.5% acetic acid at a flow rate of 20 L/min. Ion-
pair complexes were directly introduced to the mass spectrometer, and all the mass 
spectra were acquired in the positive ion mode. Electrospray ionization was achieved 
by using a spray voltage of 4.0 KV. Nitrogen was used as nebulizing gas, at a 
pressure of 20 psi. The capillary temperature was maintained at 230 °C. 
Collision-induced dissociation (CID) was performed to obtain structural 
information about the ion-pairs. Specifically, for the phosphorylated or sulfated mono- 
and disaccharide ion-pair complexes, doubly charged precursor ions were activated 
for 30 ms with 20% normalized collision energy. A qz value of 0.25 and an isolation 
width of 3 Da were used. For the ion-pairing complexes containing glycopeptides 
released from oLHα and the peptide K3, doubly charged precursor ions were 
activated with 19% normalized collision energy. All the data were acquired and 
analyzed using Xcalibur 1.3 software (Thermo, San Jose, CA).  
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3.3 Results and Discussion 
Ion pairing complexes readily form when the ion-pairing reagent is mixed with 
sulfated/phosphorylated carbohydrates. An example of the resulting MS data is 
shown in Figure 1. Recently, we demonstrated that phosphorylated and sulfated 
monosaccharides can be differentiated based on the different characteristic product 
ions of singly or doubly charged ion-pairing complexes; see Table 1.22 For doubly 
charged complexes, sulfated monosaccharides undergo sulfur-oxygen bond 
cleavage while phosphorylated monosaccharides dissociate by disrupting the 
noncovalent interaction between the carbohydrate and the ion-pairing reagent. Since 
HexNAc’s contain an amide group in their structure, the ligand dissociation can also 
be observed for the doubly charged, sulfated ion-pairs. For singly charged 
complexes, sulfated complexes undergo covalent cleavage, resulting in the losses of 
water, while the phosphorylated complexes undergo cleavage of noncovalent 
interactions, resulting in the presence of the singly charged peptide ion [K3+H]+.22 
The differences in the fragmentation pattern of these two modifications are induced 
by different chemical reactivities resulting from the slightly different pKa values of 
these two acidic groups. Since the ion-pairing MS/MS method has been 
demonstrated to be functional group specific, it should be useful in identifying 
phosphorylation and sulfation in more complex carbohydrates and glycopeptides. 
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Figure 1. (+) ESI-MS data for the phosphorylated disaccharide maltose-1-
phosphate (Mal1P) after the addition of the ion-pairing reagent Lys-Lys-Lys (K3). 
The spectrum shows two ions, [K3+H]+ and [Mal1P+K3+2H]2+.  
 
 
MS/MS of doubly charged monosaccharide:K3 ion pairs 
Owing to the successful application of ion-pairing technique in discriminating 
mono- phosphorylated and sulfated carbohydrates, we extend its utility in 
discriminating biologically relevant molecules. To this end, several diphosphorylated 
and disulfated monosaccharides, along with sulfated and phosphorylated 
disaccharides were selected (Figure 2). An initial set of experiments was performed 
to establish whether the characteristic product ions in Table 1 are preserved for 
diphosphorylated and disulfated monosaccharides, D-glucose-1,6-diphosphate 
(Glc1,6P) and N-acetyl-glucosamine 3,6-disulfate (GlcNAc 3,6S). MS/MS data 
(Figure 3) show that the mass of doubly charged precursor ions at m/z 372 and m/z 
393 are consistent with the expected mass of the ion pairs [Glc1,6P+K3+2H]2+ and 
[GlcNAc3,6S+K3+2H]2+, respectively. Two complementary ions [Glc1,6P+H]+ at m/z 
341 and [K3+H]+ at m/z 403 correspond to the dissociation of the noncovalent 
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interaction between the carbohydrate and the ion-pairing reagent, K3, in Figure 3A. 
This ligand dissociation is much more abundant for the phosphorylated complex, 
compared to the sulfated complex, because the phosphate-peptide  
 
 
Figure 2. Structures of phosphorylated and sulfated carbohydrates used for the 
ion-pairing experiments.  
 
interaction is weaker than the sulfate-peptide interaction.22 As expected, ligand 
dissociation is the most favorable fragmentation pathway in phosphorylated ion pairs.  
In Figure 3B, the ion at m/z 353, which originates from oxygen-sulfur bond 
cleavage, is observed as the base peak. Since sulfated monosaccharide:peptide 
complex is more stable than the phosphorylated ion pairs, the covalent bond 
dissociates preferentially compared to the noncovalent bonds.26 In addition, two 
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small product ions at m/z 384 and m/z 403 correspond to the ligand dissociation from 
the precursor ion. This is due to the presence of the amide group on the sulfated 
HexNAc (Table 1), facilitating the proton transfer.22 As a result, the observed 
abundant characteristic product ions in Figure 3 indicate that ion-pairing is useful in 
discriminating diphosphorylated and disulfated monosaccharides.   
 
 
Figure 3. (+) ESI-MS/MS data for the doubly charged diphosphorylated or 
disulfated ion pairs with Lys-Lys-Lys (K3): A) diphosphorylated monosaccharide 
complex [Glc1,6P+K3+2H]2+ B) disulfated monosaccharide complex 
[GlcNAc3,6S+K3+2H]2+. In (A), the precursor ion underwent the ligand 
dissociation upon CID, while (B) shows characteristic ions resulting from oxygen-
sulfur bond cleavage. Characteristic ions are marked with a star. 
 
MS/MS of doubly charged disaccharide:K3 ion pairs 
Aside from the monosaccharides, the ion-pairing approach is also applied to 
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the structurally more complex disaccharides that are phosphorylated or sulfated. 
Three phosphorylated disaccharides, maltose-1-phosphate (Mal1P), lactose-1-
phosphate (Lac1P), sucrose 6-monophosphate (Suc6P) and three sulfated 
disaccharides, heparin disaccharide IIIH (IIIH), heparin disaccharide IIIS (IIIS), 
chondroitin-6-sulfate (∆di-6S) (Figure 2) were complexed with the peptide, K3. 
MS/MS data of two isomeric phosphorylated disaccharide:peptide  ion-pairs 
(maltose-1-phosphate:K3 and lactose-1-phosphate:K3) in Figure 4 demonstrate that 
the fragmentation pattern of these two  
     
 
Figure 4. (+) ESI-MS/MS data for the doubly charged phosphorylated ion pairs with 
Lys-Lys-Lys (K3): A) [Mal1P+K3+2H]2+ B) [Lac1P+K3+2H]2+ C) [Suc6P+K3+2H]2+. 
As expected, abundant ligand dissociation ions are observed in the CID data, which 
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are characteristic for phosphorylated carbohydrates. These ions are marked with a 
star.   
 
structures is similar when the complexes are subjected to CID. In both spectra 
(Figure 4A and B), the precursor ions at m/z 413 correspond to the doubly charged 
ions, [Mal1P+K3+2H]2+ and [Lac1P+K3+2H]2+, respectively. Two complementary 
ions, [Mal1P+H]+ (Figure 4A) or [Lac1P+H]+ (Figure 4B) at m/z 423 and the peptide 
K3 ion at m/z 403, originate from ligand dissociation. Both characteristic ions are 
consistent with the expected fragmentation trends described in Table 1. Two 
interesting ions at m/z 364 and m/z 325 in Figure 4A and B correspond to the loss of 
H3PO4. The loss of H3PO4 only occurs when the carbohydrates are phosphorylated 
at the anomeric carbon.22 Thus, the loss of H3PO4 (98 Da) can be used to identify the 
position of the phosphate on the structure.22  
Figure 4C shows the MS/MS data of the doubly charged phosphorylated 
complex [Suc6P+K3+2H]2+. In this spectrum, the parent ion at m/z 413 dissociates 
into two singly charged characteristic ions, the peptide ion (K3, m/z 403) and the 
protonated disaccharide ion (m/z 423). All the other product ions are related to the 
dissociation of the glycosidic bonds and the loss of water. In summary, all the 
phosphorylated disaccharide complexes dissociated according to the fragmentation 
trends that were established based on the dissociations of phosphorylated 
monosaccharide/ion-pair complexes.   
The fragmentation of the sulfated disaccharide:peptide ion-pairs was also 
investigated, employing the same collisional dissociation (Figure 5). For the doubly 
charged complex [IIIH+K3+2H]2+ in Figure 5A,  the singly charged ion at m/z 338 
corresponds to  the characteristic ion resulting from oxygen-sulfur bond cleavage. 
Due to the presence of the amine group in the structure of IIIH, two complementary 
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ions, the singly charged peptide ion at m/z 403 and the protonated disaccharide ion 
at m/z 418, were observed (Table 1).  
Figure 5B shows the MS/MS data of the doubly charged ion-pair complex 
[IIIS+K3+2H]2+, at m/z 450.4. Four characteristic ions at m/z 338.0, 417.8, 483.0, and 
the base peak ion at m/z 410.6 originate from oxygen-sulfur bond cleavage. With an 
amine group present in the carbohydrate portion of the ion-pair complex, the 
complementary ions, singly charged peptide [K3+H]+ and protonated disaccharide 
[IIIS+H]+, should be observed. The peptide ion is observed at m/z 403.2, but an ion 
corresponding to [IIIS+H]+ is not present in the spectrum. Since the peptide ion is 
observed, the dissociation reaction obviously occurs, but the ion corresponding to 
[IIIS+H]+ probably dissociates by undergoing loss of SO3, producing the secondary 
ion at m/z 417.8.  
In the MS/MS data of the ion pair complex [∆di-6S +K3+2H]2+ in Figure 5C, 
the observed characteristic ion is m/z 380, which originates from oxygen-sulfur bond 
cleavage. Also, the expected singly charged ions, protonated sulfated disaccharide 
[∆di-6S +H]+ (m/z 460) and the singly charged peptide ion [K3+H]+ (m/z 403), are 
present. Thus, from these results it is apparent that the ion-pairing approach in 
combination with MS/MS experiments can be used to identify the phosphorylation 
and sulfation on doubly charged mono-and disaccharides. The characteristic product 
ions are useful in characterizing the acidic functional groups present on 
carbohydrates. 
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Table 1. Characteristic product ions used to differentiate phosphate and 
sulfate in monosaccharides 
 
 
Doubly charged ion pairs 
Singly 
charged ion 
pairs 
 [Hexose+K3+2H]2+ [HexNAc+K3+2H]2+ [Carbohydrat
es+K3+H]+ 
Observed 
Reaction 
Pathways 
Oxygen-sulfur 
(or oxygen-
phosphorus) 
bond cleavage 
Ligand 
dissociation 
Oxygen-sulfur  
(or oxygen- 
phosphorous) 
bond 
cleavage 
Ligand 
dissociation 
Ligand  
dissociation 
Sulfate yes no yes yes* no 
Phosphate no yes no yes yes 
*: Ligand dissociation in sulfated HexNAcs is caused by the amine group on the 
carbohydrate.  
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Figure 5. (+) ESI-MS/MS data for the doubly charged sulfated ion pairs with Lys-Lys-
Lys (K3): A) [IIIH+K3+2H]2+ B) [IIIS+K3+2H]2+ C) [∆di-6S+K3+2H]2+ As expected, the 
spectrum shows characteristic ions resulting from oxygen-sulfur bond cleavage. 
These ions are marked with a star. 
 
  
Biological application 
To test the efficacy of using the ion-pairing approach in identifying functional 
groups on larger biomolecules, a highly sulfated glycoprotein hormone oLHα (ovine 
luteinizing hormone, alpha subunit) was used as a test case. In a previous study, the 
ion pairing approach was used to enhance the signal of mono-, di-sulfated 
glycopeptides from this protein.23 Sulfated ion pairs can be readily observed in the 
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ESI-MS analysis when adding the peptide K3 to the complex mixture.23 This is 
because the peptide K3 suppresses the signal of neutral glycopeptides to facilitate 
the detection of sulfated glycoforms.23 In this study, these glycopeptides are 
complexed with the peptide, K3, to demonstrate that the presence of sulfation on the 
structure can be confirmed by the ion-pairing method.  
Four sulfated glycopeptides, which are present in the glycoprotein and 
contain different types of glycans, were selectively ion-paired with K3, and they 
formed abundant ion-pairing complexes at m/z 1065.4, m/z 1165.7, m/z 1227.3, and 
m/z 1146.3. The structures of the glycopeptides appear in Figure 6. To confirm that 
these glycopeptides contain sulfate and not phosphate, the ion-pairing complexes 
were subjected to CID experiments. MS/MS data of one of the precursor ions at m/z 
1065.4 is shown in Figure 6A. The base peak (m/z 1645.5) is an ion originating from 
oxygen-sulfur bond cleavage; this peak confirms that this glycopeptide is sulfated. 
Also, the ion at m/z 483.3 corresponding to [K3+SO3+H]+ provides the additional 
evidence for the functional group’s assignment. The complementary ions, singly 
charged K3 (m/z 403.3) and [M+H-K3]+ (m/z 1725.73), are also expected. These 
ions correspond to dissociation of the noncovalent complex, and they are expected 
for sulfated HexNAc’s.22  
The other three glycopeptides (Figure 6B, 6C, and 6D) also dissociated to 
produce the product ions that correspond to oxygen-sulfur bond cleavage. These 
ions are at m/z 1848.2 (Figure 6B), m/z 1969.3 (Figure 6C), and m/z 1807.4 (Figure 
6D). This implies that all of these glycopeptides are sulfated, which is consistent with 
the results obtained from radiolabelling.14,15 The ion at m/z 403, corresponding to the 
peptide ion [K3+H]+, is apparent on the spectrum of these glycopeptides. This ion 
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indicates that the ion pairing complexes also undergo ligand dissociation, which is 
expected for sulfated HexNAc’s. Hence, the ion-pairing approach is useful to identify 
the modifications in complex biomolecules.  
 
Figure 6. (+) ESI-MS/MS data for the doubly charged ion-pair complexes of 
glycopeptides from oLHα with Lys-Lys-Lys (K3): The characteristic ions marked 
with a star confirm that the glycopeptides are sulfated. The ions marked with a 
circle represent the ions that originated from glycosidic bond cleavage.  
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3.4 Conclusions 
The differentiation between phosphorylation and sulfation on 
monosaccharides, disaccharides, and glycopeptides is accomplished using ion-
pairing in combination with MS/MS experiments. The characteristic product ions of 
ion-pairing complexes are applicable in identifying the modification of larger 
biomolecules, such as glycopeptide mixtures obtained from ovine luteinizing 
hormone proteolytic digest. This is the first example of applying ion-pairing in 
discriminating the presence of phosphates and sulfates in complex biomolecules. 
This approach also has the added advantages of enhancing the signal of acidic 
functional groups in complex biological mixtures 23 as well as elucidating the 
structure of carbohydrate moiety of glycopeptides.24 Therefore, this 
sulfate/phosphate discrimination strategy can be successfully incorporated into a 
single synergistic approach that can be used to structurally characterize 
phosphorylated or sulfated glycoproteins, without any separation or enrichment of 
the samples prior to analysis. 
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Chapter IV 
 
Maximizing coverage of glycosylation heterogeneity in MALDI-MS analysis of 
glycoproteins with up to 27 glycosylation sites 
 
“Maximizing coverage of glycosylation heterogeneity in MALDI-MS analysis of 
glycoproteins with up to 27 glycosylation sites” by Zhang, Y.; Go, E.P.; Desaire, H. 
Submitted to Analytical Chemistry.  
 
4.1 Introduction 
Protein glycosylation is one of the essential post-translational modifications 
(PTMs), and it is involved in various biological processes.34-37, 39, 46, 58 Glycosylation 
can modify protein properties such as stability, solubility,34-38, 45 the protein’s binding 
affinity to the other biomolecules,34-38 and it can also affect inter-, intra-cell 
signaling.34-38, 59 Studying glycosylation is important because most proteins secreted 
from tissues are glycosylated and many plasma protein biomarkers are also 
glycosylated.45, 60, 61 Alteration in the glycan structures or pattern on glycoproteins 
has been implicated in several disease states, such as cancer,46, 58, 61 Alzheimer’s 
disease,48 rheumatoid arthritis,50 and chronic obstructive pulmonary disease,62 etc. 
Therefore, characterizing the glycans and monitoring the changes of glycan profiles 
are important to elucidate their biological significance and discern their roles in the 
disease process. However, the global mapping and comprehensive analysis of 
glycosylation remains a challenging task due to heterogeneous populations of 
glycans present on glycoproteins.54 As a result, maximizing the coverage of 
glycosylation heterogeneity on glycoproteins is important, especially for the biological 
variants that typically occur at low abundance.54 
There are two basic approaches to analyzing glycosylation on proteins, either 
cleaving the glycans or analyzing glycopeptides. For glycan analysis, several 
analytical methodologies have been employed, such as high performance anion-
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exchange chromatography (HPAEC),63 capillary electrophoresis (CE),64 1H nuclear 
magnetic resonance spectroscopy (1H NMR)63, microarray construction,65 and mass 
spectrometry34, 38, 39, 66-68. These techniques involve enzymatic or chemical release of 
glycans from glycoproteins, followed by a separation method then detection. 
Although these approaches have advantages to distinguish between isomeric 
structures, glycosylation site-specific information is lost, unless the glycosylation 
sites are separated prior to glycan release.69 
Mass spectrometry can also provide glycosylation site-specific information by 
conducting glycopeptide-based analysis,46, 49, 58, 61, 70-74 wherein the glycan and its 
attachment site to the protein can be elucidated in the same experiment.74 This 
glycosylation site-specific information is useful in elucidating functional properties of 
glycoprotein.74 Typically, glycopeptide-based MS analysis entails enzymatic 
cleavage of glycoproteins with an endoprotease, followed by a separation technique 
and mass analysis. Due to the high degree of heterogeneity of glycans on 
glycopeptides, the mass spectral signals of glycopeptides are suppressed by the 
strongly ionizing peptides, when both species co-exist in the complex mixture.39, 45, 51, 
58 As a result, separation and/or enrichment approaches are usually employed to 
isolate and detect glycopeptides in proteolytic digests. 
At present, several chromatographic and/or enrichment methods have been 
used for glycopeptide-based MS analysis, including reverse-phase HPLC 
fractionation,75, 76 lectin-based affinity chromatography,70, 71 and hydrophilic affinity 
methods that use porous graphitized carbon 45, carbohydrate-based resins, 46, 74 and 
hydrophilic interaction liquid chromatography,72, 77 etc. Among these methods, 
reverse phase HPLC coupled with electrospray ionization (ESI) mass spectrometry 
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has been widely used.75, 76 Lectin–based affinity chromatography is another prevalent 
approach to isolate and detect the glycopeptides. This method relies on the binding 
specificity of glycan structures,74, 78, 79 hence, the glycopeptide profile of the enriched 
fraction is dictated by the type of lectin column used for the enrichment.74 The recent 
introduction of hydrophilic affinity methods have provided a promising approach to 
isolate glycopeptides by taking advantage of the hydrophilic interactions between the 
glycans and resin materials,77 thereby, revealing the glycan profiles on glycoproteins.  
Although all of these separation and/or enrichment approaches have been utilized to 
improve the glycopeptide detection in the complex digest mixtures, there is no 
consensus in the field as to which sample separation/enrichment approaches best 
maximize coverage of glycosylation heterogeneity.   
Herein, we present an in-depth study of maximizing glycosylation coverage in 
terms of the number of glycosylation sites detected and their corresponding 
glycoforms, by optimizing all the experimental steps in the glycopeptide-based 
analysis, including sample preparative approaches, mass spectral techniques, and 
data analysis strategies. Specifically, for sample preparation, a comparative analysis 
has been performed on several approaches, such as reverse phase HPLC 
fractionation, lectin-based affinity enrichment, and hydrophilic affinity method using 
carbohydrate-based resin beads – Sepharose®.  All preparation methods are 
performed in combination with MALDI-TOF/TOF mass spectrometry, to determine an 
efficient approach for maximizing glycosylation coverage in glycan profiling. MALDI 
mass spectrometry was the chosen detection method due to its simplicity, speed, 
high sensitivity, and selectivity.34, 38, 67, 68 
 Three well-characterized glycoproteins that include immunoglobulin G (IgG), 
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transferrin, and α1-acid glycoprotein (AGP) were used as model glycoproteins in this 
study. These glycoproteins vary in terms of the number of glycosylation sites (from 
one to five) and the diversity in their glycan profiles, from mainly neutral glycans 
(IgG) to highly sialylated glycans (transferrin, AGP). Based on comparative analysis 
of sample preparation approaches, the efficacy of each sample preparative method 
is evaluated and the pros and cons for each method are described. 
In addition to addressing the issue of which sample preparation method best 
enhances glycosylation coverage, several other approaches are implemented in our 
comprehensive strategy of increasing glycosylation coverage. To optimize mass 
spectral signal of the glycopeptides, MALDI analysis was performed in both positive 
and negative ion mode to obtain the maximum glycan profiles for each glycoprotein. 
To increase the number of assigned peaks in the mass spectra, methods were 
implemented that identify glycopeptides that contain modifications on peptide 
moieties ─ such as conversion of an N-terminal glutamine into pyroglutamic acid, 
and deamination of alkylated cysteines on N-terminus. This was accomplished by 
enhancing the functionality of GlycoPep DB,80 a publicly available data analysis tool, 
built and administered by our research group, and used for all the data analysis 
completed in this study.  
Finally, PNGase F was used to cleave off the glycans in order to enhance 
glycosylation site coverage. Upon releasing the glycans from glycopeptides, the 
peptide moiety bearing the glycosylation site can be detected. This is useful because 
sometimes the presence of weakly ionizing glycopeptides cannot be detected when 
they co-elute with more strongly ionizing species; so cleaving the glycans off allows 
for the detection of the peptides that were glycosylated. While the glycan moieties 
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themselves are not identified in this technique, data about glycosylation site 
occupancy is obtained, which is another important aspect of maximizing 
glycosylation coverage on glycoproteins.   
As a demonstration of the effectiveness of the comprehensive approach we 
developed, the strategies were applied to the very heavily glycosylated HIV envelope 
protein ― JR-FL gp140 ΔCF, which contains 27 potential glycosylation sites.81 By 
optimizing each experimental step in glycopeptide-based analysis, over 85% 
glycosylation coverage was achieved on JR-FL. This study demonstrates that our 
strategies significantly improve the glycopeptide detection and maximize coverage of 
glycosylation heterogeneity on glycoproteins.  
 
4.2 Experimental Section 
Materials and reagents 
Human serum glycoproteins (IgG, transferrin, AGP), PNGase F from 
Elizabethkingia meningosepticum, urea, dithiothreitol (DTT), iodoacetamide (IAA), 
acetonitrile, sodium phosphate, sodium chloride, formic acid, trifluoroacetic acid 
(TFA), Trizma hydrochloride, Trizma base, ammonium bicarbonate, N-acetyl-D-
glucosamine, 2,5-dihydroxybenzoic acid (DHB), α-cyano-4-hydroxycinnamic acid 
(CHCA), and Sepharose® CL-4B were all purchased from Sigma (St. Louis, MO). 
The HIV envelope glycoprotein JR-FL gp140 ∆CF was expressed and purified in the 
laboratory of Dr. Barton F. Haynes, Duke Human Vaccine Research Institute 
(Durham, NC), using the method described in liturature81.  Concanavilin A (ConA) 
TopTips® and hypercarb NuTips® were purchased from Glygen Corp (Columbia, 
MD). Proteomics grade trypsin was obtained from Promega (Madison, WI). Milli-Q 
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water was obtained from a Millipore filtration system (Billerica, MA).  
Glycoprotein digestion 
Glycoproteins (100 μg-1mg) were dissolved in 100 μL of 100 mM Tris-HCl 
buffer with 6M urea, pH 8.0. Protein samples were reduced with 15 mM DTT and 
alkylated with 25 mM IAA in dark for 1 hour at ambient temperature, respectively. 
Excess IAA was removed with the addition of DTT. Prior to adding trypsin, the 
solution was diluted to less than 1M urea. Typsin was added at an enzyme-to-
substrate ratio of 1:30 (w/w). The solution was incubated overnight at 37 °C and was 
stopped by the addition of 1 μL concentrated acetic acid.  
Hydrophilic affinity method for glycopeptide enrichment 
This method follows a literature protocol3, 27 with slight modification, which 
optimizes glycopeptide detection. About 200 μg of the digest was added to a 
microcentrifuge tube packed with 20 μL Sepharose®. Then 1 mL of organic solvent 
mixture containing butanol:ethanol:water (5:1:1 by volume) was added to the digest: 
Sepharose® mixture. The resulting mixture was gently mixed for 45 min and then 
centrifuged for 5 min. The supernatant was removed and the pellet was washed 
twice with the same organic solvent. The glycopeptides were extracted by incubating 
the pellet in 1 mL ethanol:water (1:1 v/v) for 45 min. The samples were vortexed then 
centrifuged and the supernatant was transferred to another microcentrifuge tube. 
The same extraction procedure was repeated twice. The combined supernatant was 
completely dried in the Labconco centrivap cold trap (Kansas City, MO) and 
reconstituted with 100 μL of deionized water prior to MALDI analysis or HPLC 
fractionation.  
Lectin affinity method for glycopeptide enrichment  
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Con A packed TopTips® and hypercarb NuTips® were utilized according to 
the protocol recommended by the manufacturer. Briefly, Con A packed TopTips® 
were conditioned by adding 50 μL of loading buffer, 100 mM Na3PO4, 0.2M NaCl, pH 
7.0. Approximately 50 μL of digest mixture was loaded on the Con A packed bed. 
The eluate was reloaded 5 times. The packed bed was washed with 50 μL of 
washing buffer, 50 mM Na3PO4, 0.2M NaCl pH 7.0, for 2-3 times. The sample was 
eluted by the addition of elution buffer, 0.3M N-acetyl-D-glucosamine in 50 mM 
Na3PO4, 0.2M NaCl, pH 7.0. The same sample releasing procedure was repeated 3 
times. The combined eluates were concentrated to 20 μL in the Labconco centrivap 
cold trap (Kansas City, MO) and desalted using hypercarb NuTips®.  
Desalting by hypercarb NuTips® 
Before loading the sample, the hypercarb NuTips® were conditioned by 
aspirating 20 μL of the releasing solution, 40% acetonitrile with 0.05% TFA, followed 
by the binding solution, water with 0.05% TFA. The concentrated eluate from Con A 
packed TopTips® were loaded on the hypercarb NuTips® by aspirating 50 times to 
allow the maximum absorption. Then the hypercarb NuTips® were washed with 20 
μL binding solution ~10 times, and the samples were eluted by expelling the 
releasing solution ~50 times. The same releasing procedure was repeated 3 times. 
Then the combined eluate was evaporated to 10 μL prior to MALDI analysis.   
Reverse phase HPLC fractionation 
The tryptic digest mixtures were desalted and separated on a Shimadzu 
HPLC system. The mobile phase A was water with 0.1% formic acid. Mobile phase B 
was acetonitrile with 0.1% formic acid. About 20 μL of the sample was injected and 
separated on a C18 column (150×4.6mm, 5 μM, Alltech, Deerfield, IL) with flow rate 
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1mL/min at 40 °C. The fractions were collected every minute manually. Since each 
glycoprotein has different glycan structures and peptide sequences, different 
gradients were used to optimize the separation. Human IgG: initial conditions were 
5% B for 3 min, followed by a linear gradient to 40% B by 15 min, maintaining 40% B 
for another 15 min, then ramped to 85% B by 60 min. Human transferrin and JR-FL 
gp140 ∆CF: the gradient was started with 1% B and a linear gradient to 40% B was 
achieved in 50 min, then ramped to 90% B in 60 min.82 Human AGP: the column was 
equilibrated at 5% B for 3 min. A linear gradient to 20% B in 10 min were achieved, 
followed by 40% B in 60 min, then up to 100% B in 64 min.58 The collected fractions 
were dried on centrivap and reconstituted with 10 μL water, prior to MALDI analysis. 
Deglycosylation of tryptic glycopeptides by PNGase F 
PNGase F enzyme solution (≥ 500 units/mL) was prepared by adding 100 μL 
water into the sample vial of 50 units. Each glycopeptide fraction collected from 
HPLC fractionation was reconstituted with 25 μL of 20 mM ammonium bicarbonate 
buffer, pH 8.0, and treated with 2 – 4 μL of PNGase F for 3 hours at 37 °C. The 
reaction was stopped by heating to 100 °C for 10 minutes and the sample was 
directly spotted on the MALDI target plate.  
MALDI-TOF analysis and data interpretation 
The matrix used in MALDI analysis was the combination of DHB and CHCA. 
DHB and CHCA were initially dissolved in 70% ACN/ H2O to the final concentration 
of 20 mg/mL, respectively. The matrix was prepared by mixing DHB and CHCA (1:1 
V/V). The sample was mixed with the matrix solution (1:1 V/V) and 1.5 μL was 
spotted on a stainless steel MALDI target plate (Applied Biosystems, Foster City, 
CA) and air-dried. MS and MS/MS spectra were acquired on an Applied Biosystems 
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4700 proteomics analyzer. The samples were irradiated by a 355 nm Nd-YAG laser 
at 200 Hz. The acceleration voltage was 25 kV. Each mass spectrum was generated 
by averaging 3000 laser shots. In the positive ion mode, the instrument was operated 
in the reflectron mode. In the negative ion mode, the spectra were obtained in the 
linear mode. All the data were processed in Data Explorer version 4.5 (Applied 
Biosystems).  
The glycopeptide composition was assigned by using a glycopeptide web-
based tool (Glycopep DB).80 The primary sequence of two glycoproteins human IgG 
(accession number AAA02914) and transferrin (accession number NP_001054) were 
obtained from National Center for Biotechnology Information (NCBI). The peptide 
sequence of human AGP (accession number P02763) and JRFL gp 140 ∆CF was 
obtained from Swiss-Prot and the literature,81 respectively. Theoretical tryptic digest 
peptide sequences containing glycosylation sites were determined from a home-built 
glycopeptide database (Glycopep ID) by inputting primary sequence of the 
glycoproteins.83 MALDI-MS/MS data were used to confirm both peptide and glycan 
compositions of glycopeptides from the tryptic digest. Specifically, peptide 
composition was identified by two characteristic ions in the MALDI-MS/MS spectrum, 
0,2X ([peptide+83+H]+) and Y1α ([peptide+HexNAc+H]+)71, corresponding to a cross-
ring cleavage and a glycosidic cleavage, respectively. The peptide composition was 
also confirmed by internal ions observed on MS/MS spectra and deglycosylation of 
glycopeptide HPLC fractions using PNGase F. Glycan composition was initially 
assigned by using the glycopeptide web-based tool (GlycoPep DB)80 and further 
confirmed with MALDI-MS/MS data. 
 
89 
4.3 Results and Discussion 
Overview of the analytical protocols 
Aiming to determine the best strategy in maximizing glycosylation coverage 
on the glycoproteins, and subsequently, heavily glycosylated proteins like the HIV 
glycoprotein env, all the aspects of the glycopeptide-based analysis, such as sample 
preparation, mass spectral techniques and data analysis, have been optimized for 
each glycoprotein used in this study. Specifically, for optimizing the sample 
preparation approaches, a systematic comparison was conducted on reverse phase 
HPLC fractionation, lectin-based affinity, and hydrophilic affinity methods. Each 
method was evaluated in terms of the number of glycosylation sites detected and the 
glycopeptide coverage on three model glycoproteins. Figure 1 provides the 
experimental template used in this study. Model glycoproteins were first subjected to 
proteolytic digestion followed by either HPLC fractionation or/and enrichment 
methods prior to MALDI-MS analysis. To facilitate the data analysis, model 
glycoproteins were digested with trypsin. All three methods were initially applied to 
IgG, which contains one glycosylation site and a corresponding N-linked 
glycosylation profile consisting of mainly neutral glycans. Since no sialylated 
glycopeptides were detected on human IgG in the negative ion mode, the MALDI-MS 
data presented only includes analysis in the positive mode for this protein. After 
assessing the differences between glycopeptide enrichment methods using IgG, the 
applicability of each method was determined for acidic glycoproteins with two 
(transferrin) and five (AGP) glycosylation sites. 
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Figure 1. Analytical protocols used to separate or/and enrich glycopeptides of model 
glycoproteins. 
 
Comparison of three sample preparation methods on human IgG 
a) Hydrophilic affinity method using Sepharose®  
The hydrophilic affinity enrichment approach used to separate glycopeptides 
from proteolytic digest relies on the hydrogen bonding interaction between the 
glycans of glycopeptides and the carbohydrates on the resin material – 
Sepharose®.46, 74 This interaction is sufficient to bind glycopeptides allowing facile 
extraction of glycopeptides from the complex digest mixture. (+) MALDI-MS analysis 
of the glycopeptide enriched sample of IgG with Sepharose® in Figure 2A shows the 
glycopeptide profile of glycosylation site (Asn326) on the CH2 region of heavy chain. 
Seven glycan structures were observed and mainly consist of core fucosylated 
biantennary complex structures with or without a bisecting N-acetylglucosamine, 
consistent with the structures reported 
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in literature.84 In addition to heterogeneity in the glycosylation, heterogeneity in the 
peptide portion was also observed. Two peptide sequences encompassing the same 
glycosylation site, corresponding to EEQYNSTYR and EEQFNSTFR, were detected.  
b) Lectin affinity isolation using Concanavalin A (Con A) TopTips® 
Lectins are plant proteins with binding specificities for specific glycan structures.71, 85 
Among the ten known types of lectins, Con A is one of the commonly used lectins for 
glycoprotein enrichment.71, 85 Con A selectively binds to N-linked hybrid, high-
mannose, or biantennary complex type glycans.71, 86 In this experiment, Con A 
TopTips® were used for the selective enrichment of IgG glycopeptides; see Figure 
2B. Glycopeptides observed in (+) MALDI-MS measurement of the lectin enriched 
samples contain glycans with biantennary complex type and high mannose 
structures. Particularly, the glycopeptide peak observed at m/z 2892.0605 
corresponds to the high mannose glycan structure. Compared with the (+) MALDI-
MS data in Figure 2A, only a small portion of glycopeptides with a bisecting N-acetyl-
glucosamine were observed in Figure 2B because these glycopeptides have low 
affinity for Con A.46 Specifically, four glycopeptide peaks at m/z 2805, 2837, 2967, 
and 2999 observed in Figure 2A are corresponding to the glycopeptides with a 
bisecting N-acetyl-glucosamine. While only two peaks at m/z 2805, and 2967 arising 
from glycopeptides with a bisecting N-acetyl-glucosamine are present in Figure 2B. 
Using this sample preparation method, MALDI-MS measurement generated 
glycopeptides with six glycan structures consisting of fucosylated and non-
fucosylated biantennary complex type with or without a bisecting N-acetyl-
glucosamine and one high mannose glycan structure. Since Con A binds to 
glycoproteins with specific glycan structures, the selective enrichment of  
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Figure 2. (+) MALDI-TOF data of glycopeptides from human IgG separated or/and 
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enriched by different approaches: (A) hydrophilic affinity method with Sepharose®, 
(B) Con A TopTips®; (C) reverse phase HPLC fractionation. 2C shows the best 
quality data (i.e. S/N ratio). Postulated glycopeptide structures are shown. These are 
based on compositional data and biological precedence; other isomeric structures 
would also be possible.   
 
 
glycopeptides bearing glycans that have strong affinity to Con A was observed. 
Because this method is effective in selectively enriching this subset of glycopeptides, 
the lectin enrichment method using Con A is not suitable when the goal of the 
analysis is to detect the complete glycosylation profile of the protein. One obvious 
disadvantage of single lectin-based purification methods is that they bias the results 
towards whatever carbohydrate structures they have strongest affinity for, as 
observed in Figure 2. In addition, we found that the Con A TopTips® suffered from 
very poor run-to-run reproducibility, while reproducible profiles were much easier to 
obtain using the other methods.   
c) Reverse phase HPLC fractionation 
In RP-HPLC fractionation, proteolytic digests were subjected to a 
chromatographic separation using a C18 column to resolve glycopeptides in the 
digest into fractions. Each collected fraction was dried and reconstituted with H2O 
prior to analysis. Glycopeptides from the IgG tryptic digest were eluted at 6, 7, 9, and 
10 min. Figure 2C represents the (+) MALDI-MS data of the glycopeptide fraction 
eluting at 6 min. Compared to the (+) MALDI-MS data obtained from the two 
enrichment methods in Figure 2A and 2B, MALDI-MS data from HPLC fractionation 
was far superior with respect to the quality of the data (i.e, better signal-to-noise 
(S/N) ratio) and the total number of glycopeptides observed. A summary of the 
glycan compositions for all glycopeptide fractions is shown in Table 1. Overall, 
thirteen glycan structures were observed from HPLC fractionation. In addition,  
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Table 1. (+) MALDI-MS data of human IgG purified by different methods 
 
*Peptide sequence (positions 322-330) with no miscleavages; Mod: modification on peptide moieties; 
For: Formylation; F6: HPLC fraction 6 
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glycopeptide with peptide sequences, EEQYNSTYR and EEQFNSTFR, are better 
resolved in the HPLC experiment, and formylation occurs on these peptide moieties 
during fractionation. This modification is discussed in a later section of the 
manuscript. Based on these results, MALDI-MS analysis of the HPLC fractionated 
IgG glycopeptides yielded a more comprehensive glycan profile, compared to 
Sepharose® and Con A enrichment schemes; see Table 1. Thus, reverse phase 
HPLC fractionation was proven to be an efficient approach for maximizing coverage 
of glycosylation heterogeneity of glycoproteins using MALDI analysis. 
 
Sample preparation methods for human transferrin 
Having demonstrated the strength and weaknesses of each method on a 
glycoprotein with one glycosylation site, the applicability of these methods was tested 
on two glycoproteins with more than one glycosylation site, transferrin and AGP. 
Human transferrin contains two glycosylation sites with highly sialylated biantennary 
complex-type glycans.87 Compared with human IgG, identifying glycan structures of 
transferrin in MALDI-MS analysis is more challenging because it is sialylated. Sialic 
acids are labile and ionize less efficiently than neutral glycans, in the positive ion 
mode.88 To detect the sialic acids on transferrin, MALDI data was acquired mainly in 
negative ion mode. From the information obtained with IgG, the sample preparation 
approach employed for transferrin were hydrophilic affinity method using Sepharose® 
and reverse phase HPLC fractionation. Because the glycopeptide coverage of lectin-
based affinity enrichment largely depends on the lectin-glycan binding specificity, the 
application of this approach to profiling glycosylation on transferrin was not 
successful.  
a) Hydrophilic affinity method using Sepharose®  
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Glycopeptides generated from the tryptic digest of transferrin were subjected to 
hydrophilic affinity enrichment followed by (-) MALDI-MS analysis and the data is 
shown in Figure 3A. Two glycosylation sites (Asn413 and Asn611) are detected, which 
contain sialylated glycans and peptide compositions, 
QQQHLFGSN611VTDCSGNFCLFR and CGLVPVLAENYN413K. Both of these 
peptides were modified during the proteolytic digestion. In the case of tryptic peptide, 
QQQHLFGSN611VTDCSGNFCLFR, the modification arises from the formation of 
pyroglutamic acid on N-terminus. For the tryptic peptide composition, 
CGLVPVLAENYN413K, the alkylated cysteine residue was deaminated to form 5-oxo-
thiomorpholine-3-carboxylic acid.73, 89 These modifications are previously 
documented in the literature.73, 89 Two major glycan structures observed in Figure 3A 
were bi- and mono-sialylated complex-types, illustrating that this enrichment method 
is a practical approach in the identification of sialylated glycopeptides. In positive ion 
mode, no new glycopeptides were detected (data not shown). Some of the sialylated 
glycopeptides were observed; however, the signal was stronger in negative ion 
mode, as expected.  
b) Reverse phase HPLC fractionation 
For comparison, reverse phase HPLC fractionation was also evaluated in the 
analysis of glycopeptides generated from transferrin. MALDI-MS analysis of the 
glycopeptide fractions eluting at 25 and 28 min in Figure 3B and 3C show two 
glycosylation sites (Asn413 and Asn611) with peptide compositions, 
QQQHLFGSN611VTDCSGNFCLFR and CGLVPVLAENYN413K. The modifications on 
these peptides comprise deamination of glutamine, alkylated cysteine on the N-
terminus,73, 89 and formylation. The peptide sequences and modifications were  
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Figure 3. (-)MALDI-TOF data of glycopeptides from human transferrin separated 
or/and enriched by two methods: (A) hydrophilic affinity method with Sepharose®, (B) 
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reverse phase HPLC fraction eluting at 25 min (C) reverse phase HPLC fraction 
eluting at 28 min. Several modifications are present on peptide portion of the 
glycopeptides. *Peptide mod: modification on the peptide moieties. PyroCMC: 
deamination of alkylated cysteine of N-terminus; PyroQ: pyroglutamic acid of N-
terminus of peptide. For: formylation of amino groups of the peptide.  
 
 
confirmed using several approaches, including identifying peptide-based ions in 
MS/MS data and deglycosylation of glycopeptide HPLC fractions using PNGase F, 
which is discussed in a later section of this manuscript. In addition to glycopeptides 
with sialylated glycans present in the spectra, neutral glycans are also observed. 
Specifically, glycopeptide peaks observed at m/z 3081, 3098, and 3109 in Figure 3B 
and glycopeptide peaks observed at m/z 4120, and 4137 in Figure 3C correspond to 
glycopeptides with neutral glycans. Compared to Figure 3A, the relative abundance 
of di-sialylated glycopeptides decrease dramatically in HPLC fractionation and 
neutral glycopeptides are present on the spectra; see Figure 3B and 3C. According 
to the glycan structures of human transferrin reported in literature,87 over 90% 
glycans are di-sialylated biantennary complex type. Therefore, the neutral 
glycopeptides observed on Figure 3B and 3C could arise from the decomposition of 
the glycopeptides bearing di-sialic acids in the acidic HPLC fractionation, in which 
the sialic acids are hydrolyzed, and non-sialylated glycopeptides are formed. 
Although more glycopeptide peaks are observed in the HPLC fractionation for human 
transferrin, decomposition of sialylated glycopeptides were also present in the 
experiment. In addition, since glycopeptides can be better resolved in the HPLC 
fractionation, spectra with better S/N ratio were obtained in HPLC experiments, 
compared with the Sepharose® enrichment method.    
Sample preparation methods for human α1-acid glycoprotein 
From the results obtained from IgG and transferrin, all three methods were 
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able to detect all the glycosylation sites. While this is beneficial in obtaining 
glycosylation site-specific information, the glycopeptide coverage obtained from each 
method was not the same. HPLC fractionation provided better glycopeptide 
coverage. Accordingly, HPLC fractionation was used to characterize the 
glycosylation on AGP. AGP is a structurally complex glycoprotein with five 
glycosylation sites (Asn15, Asn38, Asn54, Asn75 and Asn85). The glycan profile on the 
glycosylation sites consist of highly sialylated bi-, tri- and tetra-antennary complex-
type structures.90, 91  
For (+) MALDI-MS analysis of the HPLC fractions of AGP glycopeptides, see 
Table 2A; only a few glycopeptide fractions are observed, and out of these fractions, 
only two glycosylation sites (Asn15 and Asn75), eluting between 12 –18 mins, are 
identified. The tryptic peptide sequence bearing glycosylation site Asn15 is 
CANLVPVPITN15ATLDR. Two tryptic peptides, QDQCIYN75TTYLNVQR and 
QNQCFYN75SSYLNVQR, represent the same glycosylation site (Asn75) and their 
difference in sequence is due to the peptide heterogeneity.58 The modifications on 
these peptide moieties include deamination of alkylated cysteine, glutamine on N-
terminus, carbamylation and formylation.73, 89 These modifications were verified with 
deglycosylation of glycopeptide fractions using PNGase F. Eleven glycan structures 
containing fucosylated and non-fucosylated complex-type with or without sialic acids 
were observed, as summarized in Table 2A. Table 2B contains data from the 
negative ion mode, and it is discussed in more detail later. 
Because of the relatively poor glycopeptide coverage and few glycosylation 
sites detected, we employed a two-step sample preparation approach using 
hydrophilic affinity method with Sepharose® followed by HPLC fractionation.46, 74 The 
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results (Table 3) show four glycosylation sites (Asn15, Asn54, Asn75 and Asn85) are 
observed, and thirty-three unique glycopeptide ions are identified from MALDI 
analysis of the HPLC fractions. A comparison of the data in Table 2A with those in 
Table 3 shows a marked improvement in the glycopeptide coverage and the number 
of glycosylation sites detected using the two-step sample preparation approach. 
In addition to increasing the number of glycopeptide ions detected, an additional 
benefit of improving the glycopeptide signal in the mass spectra is that MALDI-
MS/MS data can be acquired on the ions of sufficient abundance. This is critical for 
confirming the peptide assignment of the glycopeptides. Representative MALDI-MS 
and MS/MS data of the glycopeptide fraction eluting at 27 min (fraction 27 in Table 3) 
is shown in Figure 4A and 4B, respectively. The precursor ion in Figure 4B is the 
base peak at m/z 4192 in Figure 4A. Abundant glycopeptide peaks observed at m/z 
2594, 3283, and 3811 on Figure 4B were used to confirm the glycan composition. 
Glycopeptide peaks observed at m/z 2271 and 2391 correspond to 0,2X 
([peptide+83+H]+) and Y1α ([peptide+HexNAc+H]+) ions, respectively,  identifying the 
peptide composition of the glycopeptides. Peptide peaks observed at m/z 112, 175, 
403, 497, 575, 893, and 1179, were used to verify the peptide sequence. 
Among five glycosylation sites, the signal of the glycopeptides from site Asn38 
(NEEYNK) was not detected in MALDI-MS analysis. It has been observed previously 
that these glycopeptides co-elute with the glycopeptides from site Asn85 
(ENGTISR).90, 91 Since the peptide portion of the glycopeptides generated from Asn85 
ends with arginine (R), these glycopeptides ionize better than the glycopeptides from 
site Asn38, which ends in lysine (K).92 Hence, the mass spectral signal of 
glycopeptides from site Asn38 were most likely suppressed by the signal of the  
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 Table 2A. (+)MALDI-MS data of human AGP purified by reverse phase HPLC 
  
*Peptide sequence with no miscleavages; Mod: modification on peptide moieties; PyroCMC: 
Deamination of alkylated cysteine; PyroQ: pryoglutamic acid; U: Carbamylation; For: Formylation; F12: 
HPLC fraction 12 
 
Table 2B. (-) MALDI-MS data of human AGP purified by reverse phase HPLC 
 
*Peptide sequence with no miscleavages; Mod: modification on peptide moieties; PyroCMC: 
Deamination of alkylated cysteine; PyroQ: pryoglutamic acid; For: Formylation; F12 neg: HPLC fraction 
12 in negative ion mode 
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glycopeptides from Asn85. Due to the relatively low glycopeptide intensities obtained 
from this fraction compared to the other fractions, the glycans were cleaved with 
PNGase F to confirm the presence of the tryptic peptides (NEEYNK and ENGTISR). 
MALDI-MS analysis of the deglycosylated fraction indeed confirmed the presence of 
NEEYNK and ENGTISR (data not shown). Although the glycoforms could not be 
observed on site Asn38, the PNGase F experiment confirms that this site is occupied 
with glycans, therefore, increasing the number of detected glycosylation sites on this 
protein.  As demonstrated here, the use of PNGase F to identify the glycosylation 
site occupancy on the weakly ionized glycopeptides is one more strategy that can be 
implemented to maximize glycosylation coverage, when the goal is to determine 
which glycosylation sites are occupied.  
Note that MALDI-MS analysis of AGP discussed so far were performed in the 
positive ion mode. Mass analysis of the AGP glycopeptide fractions in the negative 
ion mode revealed the presence of sialylated species. Table 2B shows the sialylated 
glycans when the same fractions in Table 2A were analyzed in the negative ion 
mode. Six glycan structures were observed in (-) MALDI-MS analysis. Combining the 
glycan structures detected in both modes, a total of seventeen glycans containing 
fucosylated and non-fucosylated complex-type with or without sialic acids were 
observed.  
Representative MALDI data acquired both in the positive and negative ion 
mode of AGP glycopeptide fraction eluting at 15 min (F15 in Table 2A and 2B) in 
Figure 5 show glycopeptides with neutral glycans were mainly observed in the 
positive ion mode (Figure 5A), while sialylated species were mainly observed in the 
negative ion mode (Figure 5B). This capability to observe sialylated species in the 
negative mode improves the glycopeptide coverage.  
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Table 3. (+) MALDI-MS data of human AGP purified by Sepharose®- RP HPLC 
 
*MC: trypsin miscleavage; Mod: modification on peptide moieties; PyroCMC: Deamination of alkylated 
cystein; PyroQ: pryoglutamic acid; U: Carbamylation; For: Formylation; F4: HPLC fraction 4 
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Figure 4. MALDI analysis of glycopeptides from human AGP separated with 
Sepharose® followed by reverse phase HPLC; fraction eluting at 27min (A) 
(+)MALDI-TOF data of HPLC fraction 27, (B) (+)MALDI-TOF/TOF data of base peak 
at m/z 4192.6221 in (A) to confirm the glycopeptide assignment. 0,2X and Y1α ions are 
used to identify the peptide moieties. Postulated glycopeptide structures are shown. 
These are based on compositional data and biological precedence; other isomeric 
structures would also be possible. 
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Figure 5. MALDI-TOF data of glycopeptides from human AGP separated by reverse 
phase HPLC; fraction eluting at 15 min (A) positive ion mode; mainly neutral glycans 
on glycopeptides are detected. (B) negative ion mode; sialylated glycopeptides are 
identified. Acquiring MS data in both positive and negative ion modes improves 
glycopeptide coverage for acidic glycoproteins. *Peptide mod: modification on the 
peptide moieties. PyroCMC: deamination of alkylated cysteine of N-terminus. For: 
formylation of amino groups of the peptide. U: carbamylation.   
 
Modifications on peptide moieties of glycopeptides 
In the glycopeptide-based analysis, we detected several modifications on the 
peptide moieties that have been previously observed in the proteolytic digests of 
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proteins. These include conversion of an N-terminal glutamine into pyroglutamic 
acid,73, 89 deamination of alkylated cysteine on N-terminus when this residue was 
alkylated by iodoacetamide,73, 89 carbamylation due to the presence of urea in protein 
denaturation, and formylation when the digest mixtures were separated in acidic 
HPLC conditions. 
These modifications and their corresponding peptide sequences were confirmed by 
deglycosylation of glycopeptide HPLC fractions using PNGase F and assigning the 
MS and MS/MS data to the resulting peptides, which were generated during PNGase 
F hydrolysis. Representative MALDI-MS and MS/MS data of a deglycosylated 
glycopeptide fraction (eluting at 28 min) of human transferrin are shown in Figure 6. 
The tryptic peptide sequence bearing glycosylation site Asn611 was converted to 
QQQHLFGSD611VTDCSGNFCLFR upon deglycosylation by PNGase F. The 
modification on this peptide moiety comprises conversion of glutamine into 
pyroglutamic acid on the N-terminus, which results in a mass shift of 17 Da. Two 
peaks at m/z 2498 and m/z 2515 in Figure 6A represent the modified and unmodified 
peptide moieties of glycopeptides from human transferrin, respectively. To further 
verify the presence of modification in this fraction and the corresponding peptide 
sequences, MALDI-MS/MS data were acquired and shown in Figure 6B and 6C. The 
characteristic ions at m/z 385, 635, and 782 in Figure 6B, originating from b3, b5 and 
b6 ions are shifted 17 Da, compared to the same peaks (labeled in red) in Figure 6C. 
This demonstrates that the formation of pyroglutamic acid on N-terminus occurs 
when the glycoproteins undergo the proteolytic digestion. All the other peptide-based 
internal ions in Figure 6B and 6C were utilized to confirm the peptide sequences.    
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Figure 6. MALDI analysis of a deglycosylated glycopeptide fraction (eluting at 28 
min) from human transferrin; (A) MALDI-TOF data of HPLC fraction 28; Asparagine 
converts to aspartic acid upon deglycosylation by PNGase F. The peak marked by a 
circle represents the modification on N-terminus of the peptide: the conversion of 
glutamine into pyroglutamic acid. The peak marked by a star represents the native 
peptide. (B) and (C) MALDI-TOF/TOF data of the modified and native peptide 
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moieties. The internal peptide ions confirm the peptide sequences and the peaks 
labeled in red are used to verify the modification on N-terminus by a mass shift of 17 
Da, compared to the native peptide.  
 
 
Due to the presence of these modifications in proteolytic digest of the 
proteins, incorporating the variable modifications into the database search is helpful 
in increasing the number of mass spectral assignments of glycopeptide peaks. For 
example, in the analysis of AGP purified by the two-step preparation approach, thirty-
five glycopeptides were identified from all the fractions; see Table 3. However, out of 
thirty-five glycopeptide peaks, only sixteen glycopeptides were identified prior to 
applying the variable modifications into the database (GlycoPep DB) search. 
Therefore, considering these modifications in the assignment of glycopeptide 
compositions more than doubles the number of assignable peaks. 
Summary of the strategies used in maximizing glycosylation coverage  
As described above, each of the chromatographic or/and enrichment 
approaches was evaluated based on the number of glycosylation sites detected and 
glycopeptides identified in three model glycoproteins. The pros and cons for each 
preparative method are summarized in Table 4. In general, the hydrophilic and lectin-
based affinity enrichment methods used in this study are straightforward, selective, 
show good reproducibility (in the case of Sepharose®), and deliver moderate 
throughput for  
Table 4. Pros and cons of each sample preparation method 
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preparing several samples. While all glycosylation sites were detected in IgG and 
transferrin, the glycopeptide coverage is limited due to the lower separation 
capacities in the microcolumns, compared to HPLC fractionation. The glycan 
coverage of Con A packed lectin microcolumn tips is also limited by their glycan 
binding specificity. Although the glycan binding specificities can be improved by 
packing different lectins in one microcolumn tip, these tips are not commercially 
available. Additionally, the single lectin used in this study, Con A TopTips®, showed 
the poorest reproducibility of all the sample preparation methods.  
Reverse phase HPLC fractionation gave the best glycopeptide coverage on 
the model glycoproteins. While this approach is beneficial in achieving good 
glycosylation coverage, the throughput is relatively low and the sample 
decomposition of sialylated glycopeptides is observable, due to the acidic conditions 
of the mobile phase. The recent development and implementation of automated LC-
MALDI systems93, 94 as well as the optimization of pH in mobile phase could help to 
mitigate these problems.82 In the analysis of glycoproteins with more than two 
glycosylation sites, a two-step sample preparation method ─ Sepharose® followed by 
HPLC fractionation ─ is highly beneficial to optimize the glycosylation coverage 
because it depletes more peptides from digestion mixture, as illustrated in the 
analysis of AGP. 
 Finally, in addition to the sample preparation strategies compared here, the 
other important strategies, including the mass spectral techniques and data analysis 
strategies, were also implemented to enhance glycosylation coverage: First, profiling 
in both positive and negative ion mode in mass spectrometry is essential when 
neutral glycopeptides are intermixed with acidic ones, as is the case with AGP. 
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Second, the use of PNGase F was helpful in confirming the presence of a weakly 
ionizing glycopeptide that co-eluted with more strongly ionizing species, thus, 
increasing the number of glycosylation sites detected in glycopeptide-based analysis. 
Third, several modifications on the peptide portion commonly observed in proteolytic 
digestion, such as conversion of an N-terminal glutamine residue into pyroglutamic 
acid, and deamination of alkylated cysteine on N-terminus, can be incorporated into 
the database search (Glycopep DB)80 to facilitate assigning more glycopeptide peaks 
in data analysis.  
Application of maximizing glycosylation coverage strategies in HIV envelope 
glycoprotein 
Owing to successfully optimizing glycosylation coverage on model 
glycoproteins (from one to five glycosylation sites), the same strategies were also 
tested on a very highly complex glycoprotein, the HIV envelope protein, JR-FL gp140 
ΔCF, which contains 27 potential glycosylation sites. The proteolytic digests of JR-FL 
were subjected to RP-HPLC fractionation, with and without pre-treatment with 
Sepharose® affinity purification. Our study shows that over 300 glycoform were 
identified on 23 detected glycosylation sites from 36 HPLC fractions that contained 
glycopeptides of JR-FL in MALDI-MS analysis. Representative MALDI-MS and 
MS/MS data of a glycopeptide fraction of JR-FL eluting at 7 min (without Sepharose® 
pre-treatment) are shown in Figure 7. The two-step sample preparation method 
using Sepharose® followed by HPLC fractionation produced the same glycosylation 
coverage, compared to HPLC fractionation. In Figure 7, all the peaks marked with a 
star represent glycopeptides from glycosylation site Asn361 (LREQFEN361K) on JR-FL 
gp140 ∆CF. This single spectrum shows a total 38 glycopeptide peaks detected, with  
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Figure 7. Representative MALDI-TOF data of glycopeptide fraction (eluting at 7 min) 
from tryptic digest of JR-FL gp140 ΔCF separated by reverse phase HPLC. All the 
identified glycopeptides are from glycosylation site Asn361 on JR-FL gp 140 ΔCF and 
marked by a star.  Inset: MALDI-TOF/TOF data of the identified glycopeptide base 
peak at m/z 2711.3184. The peptide portion is LREQFEN361K and conformed by 0,2X 
and Y1α ions.  
 
good S/N ratio. Out from 38 glycopeptide peaks, 26 unique glycan structures have 
been identified, which demonstrates that a highly heterogeneous population of 
glycans can be detected from this glycosylation site. This implies that our approach 
works not only for elucidation of overall glycan profiles on glycoproteins but also for 
the identification of glycan heterogeneity in each glycosylation site. The precursor ion 
in Figure 7 inset is the base peak at m/z 2711. Glycopeptide peaks observed at m/z 
1147 and 1413 correspond to 0,2X ([peptide+83+H]+) and 
Y1α ([peptide+HexNAc+Fuc+H]+) ions, respectively,  identifying the peptide 
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composition of the glycopeptides. Since the observed peptide mass is consistent 
with the calculated mass, no modification was found on the peptide portion of the 
base peak at m/z 2711. Peptide peaks observed at m/z 253, 510, 803, and 918, 
were used to verify the peptide sequence. The glycan compositions for each of the 
starred peaks in Figure 7 were determined using GlycoPep DB and are listed in 
Supplementary Table 1 online. A full discussion of this data, along with the glycan 
profiles at the other 22 glycosylation sites detected by MALDI-MS, is presented 
separately.  
 
4.4 Conclusions 
In order to design an experimental workflow that maximizes coverage of 
glycosylation heterogeneity on glycoproteins, we optimized all the features of 
glycopeptide-based MALDI-MS analysis, including sample preparation methods, 
mass spectral data acquisition, and data analysis. This is the first study aimed at 
independently determining the best strategies to maximize glycosylation coverage in 
glycopeptide-based analysis. These strategies are useful in obtaining complete 
glycan profiles on a variety of glycoproteins (from one to multiple glycosylation sites), 
thereby facilitating understanding how glycan structure affects the functions of 
glycoproteins. This investigation also provides beneficial information in the 
experimental design for glycan profiling on heavily glycosylated glycoproteins, such 
as HIV virus envelope protein ─ JR-FL gp 140 ∆CF, which contains 27 glycosylation 
sites.   
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Supplementary Table 1. Glycopeptide composition from site Asn361 of JRFL 
gp140 ΔCF in MALDI-MS analysis  
 
*Mod: modification on peptide moieties; For: Formylation; Methyl: methylation; U: Carbamylation;  
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Chapter V 
 
Determination of disulfide bond arrangement of the oligomeric HIV envelope 
protein CON-S gp140 ∆CFI by LC/ESI-FTICR mass spectrometry 
 
5.1 Introduction 
Disulfide connectivity is one of the most essential protein modifications, and it 
plays a key role in stabilizing protein structures.95-98 Disulfide bonds are usually 
formed between thiol groups of two cysteine residues that are proximal in three-
dimensional structures in the secreted and non-cytoplasmic proteins.2, 98 The formed 
disulfide bonds provide a significant reinforcement to the native folding state of the 
protein by decreasing the conformational entropy of the unfolded state, thus, 
stabilizing the protein.98 Numerous studies have shown that the correct disulfide 
connectivity in proteins is important for protein folding and becomes an indispensable 
criterion to assess the quality of protein in recombinant DNA technology.2, 97, 99, 100 
Since disulfide linkages are essential in establishing and maintaining the proper 
protein folds, determination of disulfide bond arrangement is an important aspect to 
understanding protein chemical structures and defining the functional domains of 
proteins.100-102  
If a x-ray crystal structure of a protein is available, the disulfide bonds can be 
determined from the protein structure directly.103, 104 Likewise, if a protein structure 
has been assigned by nuclear magnetic resonance (NMR), the disulfide bonds are 
also determinable in a straightforward fashion.105 However, if this level of structural 
data is not available a priori, other methods are more appropriate. For example, 
several analytical techniques, including high performance liquid chromatography 
(HPLC),96, 106, 107 paper electrophoresis,108 and Edman sequencing96, 109 have been 
employed in the determination of disulfide bonds in proteins. These techniques were 
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used to originally characterize the disulfide bonding network in a monomeric HIV Env 
protein, from the IIIB isolate of HIV-1 generated in Chinese Hamster Ovary (CHO) 
cells.96 Typically, the disulfide bond determination by these techniques entails the 
enzymatic cleavage of proteins, followed by a separation process and then the 
detection of disulfide-linked peptides.100 Although Edman sequencing is a powerful 
tool to obtain the amino acid sequence of disulfide-linked peptides, it requires highly 
purified samples.57, 100 As a result, this approach largely hinges on the ability to 
obtain highly purified peptides, when analyzing complex samples.100 Mass 
spectrometry has emerged as an alternative analytical tool for Edman sequencing in 
determination of disulfide linkages in proteins, due to its ability to analyze peptide 
mixtures, along with its high sensitivity and throughput.  
 In addition to the analytical tools, disulfide mapping requires rigorous 
experimental controls, due to the possibility of disulfide rearrangement under certain 
circumstances. It has been previously observed that the disulfide bond scrambling 
could be triggered by the following conditions: (1) strong acid (e.g. 8.0 M sulfuric 
acid),101, 102, 110 (2) the presence of a free thiol group on unpaired cysteine residues at 
neutral pH,100-102, 110 and (3) the presence of a thiol group generated by hydrolytic 
cleavage of disulfide bonds during protein denaturation at neutral and alkaline pH. 
Thus, precautions must be taken when handling proteins to avoid disulfide bond 
rearrangement. 
The focus of this paper is two-fold: to validate an efficient method of profiling 
disulfide bonds on proteins, using liquid chromatography electrospray ionization 
Fourier transform ion cyclotron resonance mass spectrometry (LC/ESI-FTICR-MS) 
and to use the validated approach to analyze the disulfide bond arrangement in an 
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oligomeric HIV Env CON-S gp140 ∆CFI. CON-S gp140 ∆CFI was developed as a 
potential HIV vaccine candidate. It is a synthetic form of Env representing a group M 
consensus envelope protein, and it induces neutralizing antibodies against type one 
and limited type two strains of the HIV-1 virus.53 Compared to previously designed 
and synthesized immunogens, CON-S gp140 ∆CFI has marked improvement in its 
immunogenicity.53   
To date, the disulfide bonding pattern of oligomeric Env proteins, such as 
CON-S gp140 ∆CFI  has not been elucidated; however, the disulfide connectivity in 
several monomeric forms of HIV Env protein, gp120, have been described.96, 111-114 
These previous studies indicate a conserved disulfide bonding pattern is present in 
various monomeric forms of HIV Env proteins, where all cysteines are utilized for 
disulfide connectivity. While these prior studies provide useful insight into the 
connectivity of monomeric Env, this form of the protein is not the most relevant form 
for vaccine development, since it has been shown to perform inadequately as a 
vaccine candidate,115, 116 and many believe a key contributing reason is that a better 
mimic of viral Env would include protein that is present in oligomeric form.117-120 
Several oligomeric HIV Env proteins (dimers and trimers) have recently been 
expressed, and they are known to be covalently associated as a dimer or trimer 
through disulfide bonds.53, 121 This surprising result implies that the disulfide bonding 
network in recombinant oligomeric Env protein must be different from that in the 
previously characterized monomers, since at least one cysteine must be used for the 
inter-subunit disulfide bond. 
Previous studies have identified the location of inter-chain disulfide bonds 
between two subunits of Env proteins, by deleting certain domains and/or loops that 
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are suspected to be involved in the connecting disulfide bond and detecting the 
changes in the number of domains that are covalently linked in the new protein.121-123 
Although deletion mutations on a protein are useful to identify which domains and/or 
loops are involved in the inter-subunit contact of a protein, a possibility that 
truncating these segments influences the protein conformation and indirectly inhibits 
inter-subunit association cannot be ruled out.121-123 Additionally, these studies do not 
address the disulfide bonding which is not associated with the inter-subunit linkage. 
The study presented herein is the first investigation to fully characterize the 
disulfide bonding network of an oligomeric Env protein, CON-S gp140 ∆CFI, and 
identify the exact location of an inter-subunit disulfide bond in HIV Env protein, using 
high resolution FTICR mass spectrometry. Our results show that two functional 
domains previously identified in a monomeric Env protein, the third and forth variable 
regions (V3, V4), are also conserved in the disulfide bonding in CON-S gp140 ∆CFI. 
Among these two regions, V3 is the immunodominant region that is responsible for 
inducing neutralizing antibodies.53 One cysteine residue Cys225 was identified as 
forming an inter-subunit disulfide bond between two Env monomers, accounting for 
the oligomeric nature of CON-S gp140 ∆CFI. Interestingly, five free cysteine residues 
are present in the N-terminal region (defined by amino acid residues 1-250) of CON-
S gp140 ∆CFI. Our results demonstrate that the oligomeric form of an HIV Env 
protein possess a different disulfide bonding network, compared to the monomeric 
HIV Env protein. This information will facilitate understanding how the disulfide bond 
arrangement correlates to immunogenetic activities of the oligomeric form of HIV Env 
protein. This study also sets the foundation for further work: Assessing the 
differences in disulfide bonding patterns of recombinant Env proteins and comparing 
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them to the disulfide bonds pattern on Env isolated from virions; these studies would 
make it possible  to determine what types of recombinant proteins best mimic the 
native viral Env protein. Such studies would greatly aide in the generation of an 
effective vaccine against the HIV-1 virus.  
 
5.2 Experimental Section 
Materials and reagents 
Albumin from bovine serum (BSA), 4-Vinylpyridine, acetonitrile, formic acid, 
acetic acid, and ammonium bicarbonate were all obtained in high purity from Sigma-
Aldrich (St. Louis, MO). The HIV envelope glycoprotein CON-S gp140 ∆CFI was 
expressed and purified in the laboratory of Dr. Barton F. Haynes, Duke Human 
Vaccine Research Institute (Duke University, Durham, NC), using the method 
described elsewhere53. Peptide N-glycosidase F (PNGase F) from Elizabethkingia 
meningosepticum and proteomics grade trypsin were purchased from Calbiochem 
(San Diego, CA) and Promega (Madison, MI), respectively. Ultra-pure water was 
obtained from a Millipore Direct-Q3 filtration system. (Billerica, MA). 
N-deglycosylation of CON-S gp140 ∆CFI  
 A sample containing approximately 100 μg of HIV envelope protein CON-S 
gp140 ∆CFI was dissolved in 50 mM ammonium bicarbonate buffer (pH 7.0) and 
treated with 1 μL of PNGase F enzyme solution (≥ 4500 units/mL). The reaction was 
incubated at 37 °C for one week. 
Protein digestion 
The protein, either BSA or deglycosylated CON-S gp140 ∆CFI, was dissolved 
in 50 mM ammonium bicarbonate buffer (pH 7.0). Prior to enzymatic digestion, 
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unpaired cysteine residues in BSA or deglycosylated CON-S gp140 ∆CFI were 
alkylated with 4-Vinylpyridine at a protein:alkylating reagent ratio of 1:6 (molar ratio). 
The resulting solution was incubated in the dark for 1 hour at ambient temperature. 
Proteins were then digested at 37°C with trypsin at an enzyme-to-substrate ratio of 
1:20 (w/w) for 18 hours, followed by a second trypsin addition under the same 
conditions. The digestion was stopped by the addition of 1μL concentrated acidic 
acid and the resulting protein digest mixture was analyzed by reverse phase-
HPLC/ESI-FTICR MS.     
LC/ESI-FTICR MS analysis 
The tryptic digestion mixtures were subjected to reverse phase high 
performance liquid chromatography (RP-HPLC, Dionex, Sunnyvale, CA) coupled 
with a hybrid linear ion trap-Fourier transform ion cyclotron resonance mass 
spectrometer (LTQ-FTICR-MS) equipped with a 7 Tesla actively shielded magnet 
(ThermoElectron Corp, San Jose, CA).  The mobile phase A was 99.9% water with 
0.1% formic acid. Mobile phase B was 99.9% acetonitrile with 0.1% formic acid. 
Approximately 10 μL of the sample was injected and separated on a C18 PepMap 
300TM column (150mm×300 μm i.d. 5 μM, 300Å; LC Packings, Sunnyvale, CA) at a 
flow rate of 5μL/min. The tryptic peptides were eluted using the following gradient, 
which was modified from the method described in the literature124: The mobile phase 
initially contained 2% B and the level of B increased linearly to 40% over 30 min, 
then ramped to 90% B over 20 min. The column was re-equilibrated after holding at 
90% B for 10 min. 
The samples were infused into the electrospray ion source, and the hybrid 
LTQ-FTICR data acquisition was performed in a data-dependent scanning mode. 
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Briefly, the MS1 spectra were recorded in FT-MS scan and the three most intense 
peptide ions in MS scan were sequentially selected for CID experiment performed in 
the LTQ mass analyzer, with 25% normalized collision energy and a 3 min dynamic 
exclusion window. Electrospray ionization was achieved with a spray voltage of ~ 4.0 
kV. Nitrogen was used as nebulizing gas and set at a pressure of 10 psi. The 
capillary temperature was maintained at 200 °C. All the data were acquired in the 
positive ion mode and analyzed using Xcalibur 1.3 software (ThermoElectron Corp, 
San Jose, CA).   
 
5.3 Results and Discussion 
To demonstrate the effectiveness of our approach in disulfide mapping using 
LC/ESI-LTQ-FTICR-MS analysis, a disulfide-rich protein, bovine serum albumin 
(BSA), was chosen as a model protein to optimize experimental conditions. This 
approach was subsequently applied in the determination of disulfide bond 
arrangement of HIV Env protein CON-S gp140 ∆CFI.  
Disulfide mapping of bovine serum albumin 
Bovine serum albumin (primary accession number P02769 from Swiss-Prot)  
contains ~600 amino acid residues, 77 potential cleavage sites for trypsin, and 35 
cysteine residues.125 The putative disulfide bond arrangements126 are shown in 
Figure 1, in which 17 inter- and intra-chain disulfide linkages are formed. One 
unpaired cysteine residue, Cys58, has a free thiol group, and it could promote the 
disulfide bond rearrangement at neutral pH ~7.0.100 To preclude disulfide scrambling, 
the thiol groups in the unpaired cysteine residues were masked with the addition of 
excess alkylating reagent, 4-Vinylpyridine. 4-Vinylpyridine is an ideal alkylating agent 
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because the modified peptides containing S-β-(4-pyridylethyl)-cysteine can be 
readily identified, due to the presence of characteristic ion, S-pyridylethyl moiety, 
 
 
Figure 1. Protein sequence and theoretical disulfide-linkage arrangement in bovine 
serum albumin; Disulfide linkages are indicated with a solid line and cysteine 
residues are shown in red.  
 
upon CID experiments in mass spectrometry.127 The protein was then digested with 
trypsin at neutral pH ~7.0. Trypsin was used for generating the disulfide-linked 
peptides due to its substrate specificity and its capability to produce relatively simple 
mass spectra, compared to other proteases (e.g. pepsin).100 The resultant tryptic 
peptides containing disulfide linkages and modified unpaired cysteine residues were 
then subjected to reverse-phase HPLC followed by ESI-FTICR MS and MS/MS 
analysis, as shown in Figure 2.  
When the tryptic digestion mixtures were separated, several clusters of 
peptides with inter- or/and intra-disulfide linkages were identified. A representative 
reverse-phase HPLC chromatogram and LC/ESI-FTICR MS data of tryptic peptides 
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from BSA are shown in Figure 3A and B, respectively. The FTICR-MS spectrum of 
the HPLC fraction eluting between 16-17 min (the red bar shown in Figure 3A) shows 
two peaks at m/z 925.8946 and m/z 1234.1892 with different charge states. Figure 3 
inset shows the zoomed-in spectra used to identify the monoisotopic peaks at m/z 
925.3933, m/z 1234.5219 and their corresponding charge states (+4, and +3, 
respectively). By comparing the observed masses resulting from the tryptic protein 
digests with the theoretically calculated masses of the putative disulfide-linked 
peptides, the peaks at m/z 925.3933 and m/z 1234.1892 were identified as 
corresponding to a three-chain disulfide-linked peptide found in BSA. This is the third 
entry in Table 1, which summarized all the experimentally determined disulfide 
linkages in BSA. All the 35 cysteines have been identified by LC/ESI-FTICR MS 
analysis. Each cluster of peptides containing disulfide linkages or unpaired cysteine 
residues has been identified with high mass accuracy, which is consistent with the 
known disulfide linkages in BSA, as described in literature.108, 126  
To further verify the disulfide linkages and peptide sequences of these 
peptide clusters, MS/MS analysis was performed using data dependent acquisition in 
the linear ion trap. Representative LC/ESI-LTQ-FTICR MS/MS data are shown in 
Figure 4. Three classes of peptides containing disulfide-linkages or unpaired 
cysteine residues have been identified by the product ions observed in MS/MS 
analysis. Figure 4A depicts the CID data of a peptide that contains a cysteine capped 
with 4-Vinylpyridine. The major ions in the spectrum are consistent with the expected 
peptide sequence that retains the chemically modified thiol group on the cysteine. 
Figure 4B represents an intra-chain disulfide-linked peptide from BSA. For the 
product ions at m/z 407.22, 438.09, 566.39, 849.24, and 860.88, in which the  
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Figure 2. Schematic representation of disulfide bond mapping work-flow in (A) bovine 
serum albumin and (B) CON-S gp140 ΔCFI; The pink ball represents the glycans on 
CON-S gp140 ΔCFI. The yellow star indicates the free cysteines alkylated by 4-
Vinylpyridine. 
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disulfide bonds are dissociated, the termini of the cysteine residues were detected as 
thiol groups (-SH), as expected.98 Again, the MS/MS data is highly consistent with 
the depicted peptide sequence. Figure 4C demonstrates the identification of a three-
chain disulfide-linked peptide. The product ions denoted y/b were generated from the 
peptide chain containing an N- terminal serine (S), whereas product ions denoted 
Y/B and yn’/bn’ (n’=1-7) were produced from the peptide chains with N terminal 
glutamic acid (E) and asparagine (N), respectively. As demonstrated here, in addition 
to using high mass accuracy data in FTICR-MS analysis to identify the disulfide-
linked peptides in BSA, the peptide sequences and disulfide linkages in these 
peptides were also confirmed with MS/MS experiments, which significantly increases 
the confidence level in the mass assignments and implicates that our approach is an 
effective way to determine the disulfide bonds in complex protein digests.  
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Figure 3. Representative (A) reverse-phase HPLC chromatogram and (B) LC/ESI-
FTICR MS data of tryptic peptides from bovine serum albumin; The tryptic peptides 
are separated within a 60-min gradient. The mass spectrum of HPLC fraction eluting 
at 16-17 min (labeled with a red bar in A) shows two peaks (in red) with different 
charge states corresponding to the tryptic peptides with two inter-chain disulfide 
linkages. Inset: The zoomed-in spectra of detected disulfide-linked peptide peaks, 
used to identify the monoisotopic peaks and charge states. 
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Table 1. Summary of the disulfide linkages in bovine serum albumin 
 
 
*: The free Cysteine is alkylated by 4-vinylpyridine. 
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Figure 4. Representative LC/ESI-FTICR MS/MS data for the disulfide-linked tryptic 
peptides from bovine serum albumin; (A) peptide with a free cysteine residue; (B) 
peptide with an internally linked disulfide bond; (C) peptides with two inter-chain 
disulfide linkages.  
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Disulfide mapping of CON-S gp140 ∆CFI 
Owing to the successful application of this approach in disulfide mapping of 
bovine serum albumin, we extend its utility to a structurally complex protein CON-S 
gp140 ∆CFI.  
CON-S gp140 ∆CFI is a synthetic form of the HIV-1 Env protein; in small 
animal vaccine trials, it was shown to induce type I and limited type II neutralizing 
antibodies against the HIV-1 virus.53 This protein contains ~600 amino acid 
residues53, 52 potential cleavage sites for trypsin, 18 cysteine residues, and 31 
potential N-linked glycosylation sites, attached with a heterogeneous population of 
glycans.128 It is expressed mainly as a dimer. According to the disulfide connectivity 
in a previously analyzed recombinant, monomeric HIV Env protein,96 nine disulfide 
bonds should be present for each monomeric unit of CON-S gp140 ∆CFI, if the 
disulfide bonding pattern is conserved. This “expected” disulfide connectivity for the 
monomeric form of CON-S gp140 ∆CFI is shown in Figure 5A, in which the disulfide 
bonds define the boundaries of the variable regions (V1-V5) as well as conserved 
domains in HIV Env protein.96, 129 Since CON-S gp140 ∆CFI used in this study is an 
oligomeric form of Env, we accounted for the possibility that the disulfide bonding 
pattern could be significantly different. Therefore, many possibilities for the disulfide 
connectivity were considered and investigated in data analysis, including free 
cysteine residues, the disulfide bonding pattern observed previously,96 new disulfide 
bonds within the monomeric unit and inter-chain disulfide bonds between two 
monomeric units.      
One final obstacle in analyzing disulfide bonds of CON-S gp140 ∆CFI is dealing with  
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Figure 5. Overview of (A) “Expected” disulfide-linkages based on the disulfide bond 
arrangement of a previous analysis of a monomeric form of HIV Env protein 
expressed in CHO cells.96 and (B) experimentally determined disulfide linkages in 
CON-S gp140 ΔCFI. (A): disulfide linkages are indicated with a solid line and 
cysteine residues are shown in red; (B): cysteine residues shown in red and green 
represents the identified and non-identified cysteines, respectively. The cysteines 
136 
labeled with a star represent the free cysteines. The cysteine labeled with a circle 
indicates a formed inter-subunit disulfide bond to connect two monomeric units in 
CON-S gp140 ΔCFI. The disulfide linkages are indicated with a solid line and the 
variable regions (V1 to V5) are labeled. 
 
 
protein glycosylation. This protein is extensively glycosylated. The glycans are bulky 
and block proteases from accessing the peptide backbone. This would result in 
multiple missed cleavage sites during enzymatic digestion, thus producing 
complicated spectra in MS analysis. As a result, the glycans attached to CON-S 
gp140 ∆CFI were cleaved prior to the disulfide mapping, to facilitate trypsin 
digestion. 
  
Control experiment to validate the deglycosylation step in disulfide mapping of CON-
S gp140 ∆CFI 
While the deglycosylation step is essential in assigning the disulfide bond 
arrangement of CON-S gp140 ∆CFI, it is possible that this process would result in 
disulfide scrambling. Herein, we introduced a control experiment to investigate this 
possibility. The validation protein, bovine serum albumin, was incubated with 
PNGase F at 37 °C for one week, followed by alkylation with 4-Vinylpyridine and 
tryptic digestion. The resultant tryptic peptides containing inter-/intra-disulfide 
linkages were subjected to LC/ESI-FTICR-MS analysis. Our study shows that the 
same disulfide connectivity in BSA is obtained, compared to the results described in 
the previous section. This demonstrates that the conditions described herein for the 
extra deglycosylation step do not affect the determination of disulfide linkages in 
glycoproteins.  
Determination of disulfide bonds in CON-S gp140 ∆CFI 
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A schematic work-flow of disulfide-mapping in CON-S gp140 ∆CFI is shown 
in Figure 2B. The glycoprotein was enzymatically deglycosylated with PNGase F by 
incubating the protein:enzyme solution at 37°C for one week. The enzymatic release 
of glycans converts asparagine in the peptide consensus sequence NXT/S to 
aspartic acid, which results in a mass shift of 1 Da; see Scheme 1. 
 
It is necessary to know which asparagines (N) would be converted to aspartic acids 
(D) during deglycosylation, so that the theoretical masses of each peptide would be 
elucidated; therefore, the glycosylation site occupancy of the protein must be known 
or determined. The determination of glycosylation site occupancy in CON-S gp140 
∆CFI was achieved and described in a previous work.128 Accordingly, the cysteine-
containing tryptic peptides from CON-S gp140 ∆CFI with fully or partially occupied 
glycosylation sites and their corresponding deglycosylated peptide masses are listed 
in Table 2. The masses in this table were used to generate theoretical masses for a 
wide variety of possible disulfide-linked peptides, as described above, and this list of 
theoretical masses was interrogated against the mass spectral data, in order to 
determine the disulfide connectivity of this protein.  
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Table 2. Glycosylation sites occupancy on the Cys-containing tryptic peptides 
of CON-S gp 140 ΔCFI  
 
 
 
The mass spectral data was acquired by first subjecting the deglycosylated 
CON-S gp140 ∆CFI to tryptic digest, then obtaining an LC/ESI-FTICR-MS analysis. 
Representative reverse-phase HPLC chromatogram and ESI-FTICR MS data of 
tryptic peptides from deglycosylated CON-S gp140 ∆CFI are shown in Figure 6A and 
B, respectively. The FTICR-MS spectrum of HPLC fraction eluting between 14-15 
min (the red bar shown in Figure 6A) shows a doubly charged peak at m/z 788.8779 
originating from an intra-chain disulfide linked peptide, LINCDTSAITQACPK. Figure 
6 inset shows a zoomed-in spectrum of this peak, which is used to identify the 
monoisotopic peak at m/z 788.3805 and its corresponding charge state. The aspartic 
acid residue (labeled in green) was generated upon deglycosylation with PNGase F, 
as described above.  
The summary of all the experimentally determined disulfide linkages in CON-
S gp140 ∆CFI is shown in Table 3. Only two interchain disulfide linked peptides were 
detected as having a disulfide bonding pattern consistent with the disulfide bonding 
observed in the previous analysis of a monomeric form of Env protein.96 These two 
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disulfide-linked peptides form the third and forth variable regions (V3, V4) in CON-S 
gp140 ∆CFI. It is worth noting that the V3 loop is an immunodominant region, which 
is responsible for the generation of a wide range of neutralizing antibodies.53 Aside 
from these two disulfide-linked peptides, which are consistent with the “expected” 
disulfide-linkages for monomeric Env,96 several peptides with unpaired cysteine 
residues, intra-, and inter-chain disulfide linkages were identified, which are also 
listed in Table 3. Most notable in this group of newly-described disulfide bonding is 
the tryptic peptide CNDKK, which forms an inter-subunit disulfide bond, where a 
disulfide bond connects the same peptide region present in two monomeric units. 
This disulfide-linked peptide demonstrates the exact cysteine residue responsible for 
the oligomerization of this protein.  
To further verify each of the disulfide linkages and peptide sequences of 
these peptide clusters, MS/MS analysis was performed. In each case, the MS/MS 
data is consistent with the assignments presented in Table 3. Representative 
LC/ESI-LTQ-FTICR MS/MS data are shown in Figure 7. Three classes of peptides 
containing intra-, inter-, and self-linked disulfide bonds have been confirmed by the 
fragmentation ions observed in the MS/MS analysis. Figure 7A depicts the 
fragmentation of a peptide with an intra-chain disulfide linkage. For the product ions 
at m/z 779.74 and 874.77, in which the disulfide bonds are dissociated, the termini of 
the cysteine residues were detected as thiol groups (-SH), as expected, based on 
prior work.98 The ion at m/z 975.50, with an intact disulfide bond, demonstrates that 
this peptide indeed contains an intra-chain disulfide linkage. All of the other major 
ions in the spectrum are also assignable, and consistent with the peptide sequence 
shown on the Figure. 
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Figure 7B and C represent the verification of an interchain disulfide-linked 
peptide and the peptides forming an inter-protein disulfide bond, connecting the two 
monomeric subunits in CON-S gp140 ∆CFI, respectively. In Figure 7B, the product 
ions denoted y/b were generated from the peptide chain with an N-terminal threonine 
(T), whereas product ions denoted Y/B were produced from the peptide chains with 
N-terminal isoleucine (I). As in Figure 7A, the data in 7B and 7C clearly show that the 
MS/MS data is highly consistent with the assignment for each precursor ion, further 
validating the data in Table 3.   
 An overview of the experimentally determined disulfide bonds from this study 
is shown in Figure 5B. In the N-terminal region (defined by amino acid residues 1-
250) of CON-S gp140 ∆CFI, six cysteine residues form intra-, and inter-chain 
disulfide bonds; one cysteine residue forms an inter-protein disulfide bond which 
connects the same regions of two monomeric units in CON-S gp140 ∆CFI; and five 
unpaired cysteine residues are present in the early region of the protein. While the 
disulfide connectivity in the N-terminal region of the protein is completely different, 
the disulfide linkages from V3 and V4 regions are consistent with the putative 
disulfide bonds in a previous analysis of a monomeric form of Env protein.96 Overall, 
out of 18 cysteine residues in CON-S gp140 ∆CFI, 16 cysteine residues have been 
identified by LC/ESI-FTICR MS analysis. Two cysteine residues within the V4 loop, 
Cys380 and Cys409, were not detected. This is probably due to the fact that the tryptic 
peptide generated within V4 loop would be large, and it contains numerous acidic 
amino acid residues, so its ionization efficiency in MS would be problematic. 
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Figure 6. Representative (A) reverse-phase HPLC chromatogram and (B) LC/ESI-
FTICR MS data of tryptic peptides from CON-S gp140 ΔCFI; The tryptic peptides are 
separated within a 60-min gradient. The MS spectrum of HPLC fraction eluting at 14-
15 min (labeled with a red bar in A) shows a peak at m/z 788.8779 (in red) 
corresponding to the disulfide-linked tryptic peptides. Inset: The zoomed-in spectrum 
of the detected disulfide-linked peptide peak, which is used to identify the 
monoisotopic peak and charge state.  
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Table 3. Summary of the disulfide linkages in CON-S gp140 ΔCFI detected by 
LC-LTQ-FTICR 
 
 
*: free cysteines are alkylated by 4-vinylpyridne; Asparagine in NXT/S is converted to aspartic 
acid upon deglycosylation and labeled in green.  
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Figure 7. Representative LC/ESI-FTICR MS/MS data for the disulfide-linked tryptic 
peptides from CON-S gp140 ΔCFI (A) peptide with an internally linked disulfide 
bond; (B) disulfide-linked peptides within the V4 loop (C) peptide with a self-linked 
disulfide bond,  showing where the inter-subunits contact point in CON-S gp140 
ΔCFI is located. N’ and K’ indicate that the side chain of asparagine and lysine are 
cleaved, while the peptide backbone remains intact.  
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Biological implications of this study 
The results obtained from this study demonstrate that the disulfide 
connectivity of CON-S gp140 ∆CFI is dramatically different than the disulfide 
linkages in the previously analyzed monomeric form of HIV Env protein expressed 
from CHO cells96 (Figure 5A),  especially in the N-terminal region of protein where 
the first and second variable regions (V1, V2) are normally formed.  
Our findings complement a previous study by Jobes et al, which shows that 
the V1 and V2 regions of Env are highly variable, with the respect to the cysteine 
content.129 These authors suggest that when the insertion or deletion of cysteine 
residues occurs in these regions, it could result in the disruption of normal disulfide 
bonds.129 Both our work and this previous work show that the cysteine residues in 
the N-terminal region of Env can have a varying disulfide connectivity. The V1 and 
V2 region of the protein are important, because they shield the V3 region, preventing 
antibodies from directly accessing neutralizing epitopes present in V3.129-131 Since 
the disulfide linkages of the V1 region in CON-S gp140 ∆CFI are connected 
differently than those described previously,96, 111-114 and many unpaired cysteine 
residues are present, the disulfide connectivity in CON-S gp140 ∆CFI may cause the 
epitopes in the V3 region to be more exposed, facilitating immune response to this 
region. 
In addition, our study identified an inter-subunit disulfide bond via the self-
linked peptide, CNDKK. This peptide is near the V2 loop and is responsible for the 
oligomeric nature of CON-S gp140 ΔCFI.53 This result can be used to support and 
further clarify previous studies that reported the deletion of the V2 domain on the HIV 
Env causes the disruption of dimeric protein conformation, implicating that this region 
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would be involved in the inter-subunit connection in the oligomeric form of Env 
protein.122 
Aside from the disulfide linkages in V1 and V2 regions, the final interesting 
implication of this work relates to the disulfide linkage in the V3 loop, which is 
identified in our study to be consistent with the disulfide bonding established for 
monomeric Env.96, 111-114 This is somewhat expected, since this region was 
determined to be immunodominant, and it contributes to the improved 
immunogenicity in CON-S gp140 ∆CFI.53 As demonstrated here, the disulfide bond 
arrangement in the N-terminal region of CON-S gp140 ∆CFI is not in agreement with 
the putative disulfide linkages in literature;96 however, marked improvement of 
immunogenicity in CON-S gp140 ∆CFI was obtained and described previously.53 
This implies that satisfactory immune response may rely on several factors including 
the presence of V3 loop, the degree of accessibility to the neutralizing epitopes on 
this region, and the oligomeric conformation of Env protein, etc. Further study of the 
correlation between the disulfide linkages in Env protein and its immune response 
will provide more information on understanding how the antigenic structures affect 
the immnogenicity. The disulfide bond mapping for other synthetic and wild-type 
recombinant Env proteins is on-going and will be presented separately.  
  
5.4 Conclusions  
Aiming to elucidate the correlation between the structure of the HIV-1 Env 
protein and its immunogenicity, we developed a MS-based approach, LC/ESI-FTICR, 
to characterize the disulfide linkages on the Env protein CON-S gp140 ∆CFI. Prior to 
applying this approach to the Env protein, the method was validated using a 
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disulfide-rich protein, bovine serum albumin. In this protein, all the 35 cysteine 
residues were detected. A total 17 disulfide-linked peptides and 1 unpaired half-
cysteine residue were identified with high mass accuracy, and confirmed by MS/MS 
experiments. This data is in agreement with the putative disulfide linkages reported 
previously for BSA.126 
 This approach was then applied to elucidate the disulfide connectivity in 
CON-S gp140 ∆CFI. Out of 18 cysteine residues, 16 cysteine residues were 
identified. In the N-terminal region of CON-S gp140 ∆CFI, one cysteine residue 
Cys225 was identified as forming an inter-subunit disulfide bond, stabilizing the 
dimeric composition of this HIV-1 Env protein. Six cysteines are involved in forming 
disulfide bonds within the monomeric units. In addition to the cysteines that are 
utilized in disulfide bond connectivity, five free cysteine residues are present in the N-
terminal region of CON-S gp140 ∆CFI.  
Although the cysteine residues in the N terminal region of the protein are 
different from the putative disulfide linkages from an analysis of a monomeric form of 
HIV Env protein,96 the V3 and V4 loops formed in the later region of the protein are 
indeed identified in CON-S gp140 ∆CFI. Among these two regions, the V3 loop is 
immunodominant and contributes to the improved immunogenicity of CON-S gp140 
∆CFI. The disulfide bond determination of CON-S gp140 ∆CFI indicates that the 
satisfactory immune response may depend on several factors including the presence 
of the V3 loop, the degree of accessibility to the neutralizing epitopes on this region, 
and the oligomeric conformation of Env protein, etc.   
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Chapter IV 
Conclusions 
In order to understand biological functional properties of glycoproteins, 
several efficient MS-based approaches have been developed in this study to 
characterize glycans on the glycoproteins.  
To identify the acidic functional groups (sulfate, and phosphate) on the 
carbohydrates and glycopeptides, an ion-pairing strategy in conjunction with ESI-
MS/MS was developed on the model phosphorylated and sulfated monosaccharides 
to differentiate between these two functional groups. Since both sulfate and 
phosphate are highly acidic compounds with different proton affinities, differences in 
the chemical reactivities with the ion-pairing reagents can be used to differentiate 
these isobaric compounds in MS/MS experiments. This approach was subsequently 
applied to the other biological relevant molecules, such as mono-, di-saccharides, 
and sulfated glycopeptides to differentiate phosphorylation and sulfation on these 
species.  
 Aside from identification of acidic glycans on the glycoproteins, we also 
designed an experimental workflow that maximizes coverage of glycosylation 
heterogeneity on glycoproteins that vary in the number of glycosylation sites and 
their corresponding glycan profiles. All the features of glycopeptide-based MALDI-
MS analysis, including sample preparation methods, mass spectral data acquisition, 
and data analysis were optimized. In doing so, we designed a work-flow for glycan 
profiling on heavily glycosylated glycoproteins, such as HIV virus envelope protein ─ 
JR-FL gp 140 ∆CF, which contains 27 glycosylation sites. Out of 27 glycosylation 
sites, 23 glycosylation sites and over 300 glycoforms have been detected on this 
152 
protein.  
In addition to glycan profiling on glycoproteins, disulfide connectivity is 
another predominant feature in elucidation of chemical structure of a protein and 
define its functional domains. Aiming to elucidate the correlation between the 
structure of HIV Env protein and its immunogenicity, we validated a MS-based 
approach, LC/ESI-FTICR, by characterizing the disulfide linkages on bovine serum 
albumin to optimize the experimental conditions. This approach was subsequently 
applied in the determination of disulfide bonds in a HIV Env protein CON-S gp140 
∆CFI. In this protein, out of 18 cysteine residues, 16 cysteine residues were 
identified. Two functional domains previously identified in monomeric Env protein, 
the third and forth variable regions (V3, and V4), are also conserved in the disulfide 
bonding in CON-S gp140 ∆CFI. One cysteine residue Cys225 was identified as 
forming an inter-subunit disulfide bond to stabilize the oligomeric structure of CON-S 
gp140 ∆CFI. Aside from the cysteines that are utilized in disulfide bond connectivity, 
the peptides with free cysteine residues are also present in CON-S gp140 ∆CFI. The 
information obtained from this study will facilitate understanding how the disulfide 
bond arrangement correlates to immunogenetic activities of oligomeric form of HIV 
Env protein and may also provide the insights into the direction for the future vaccine 
development. 
 
 
 
